Índice

• Symposia

  • ·Food for thought: understanding and treating eating disorders

    Página :1-1

    W. Vandereycken

    
  • ·Post genomic psychiatry: the effect of the human genome project on clinical practice

    Página :1-1

    P. McGuffin

    
  • ·A randomised Methadone-controlled heroin trial in opiod-addicts

    Página :1-1

    W. van den Brink

    
  • ·Two new methods of rapid detoxification in opioid dependence: what does general anaesthesia really add to the effect?

    Página :1-1

    C.A.J. de Jong

    
  • ·Sertraline alcoholics with major depression: a controlled trial

    Página :1-1

    A. Gual

    
  • ·Combining acamprosate and naltrexone in the treatment of alcoholism, results from a randomized placebo controlled trial

    Página :2-2

    F. Kiefer, K. Wiedemann

    
  • ·Galanthamine - a cholinergic patch to treat alcoholics? Results of a RCT

    Página :2-2

    K. Mann, T. Scherle, B. Croissant, H. Nakovics

    
  • ·Patient treatment concordance in schizophrenia

    Página :2-2

    C. Bingefors

    
  • ·Old versus new antipsychotic drugs in relation to treatment concordance

    Página :2-2

    W. Wolfgang Fleischhacker

    
  • ·Compliance training programs

    Página :2-2

    I.-M. Wieselgren

    
  • ·260 therapeutic drug monitorings (TDM) in relation to compliance and co-medication in psychiatric treatment

    Página :3-3

    F. Bengtsson

    
  • ·The importance of drug metabolic pheno- and genotype in psychiatric co-medication issues

    Página :3-3

    P. Baumann

    
  • ·Treatment-resistant depression

    Página :3-3

    M. Trimble

    
  • ·Pharmacological approaches to resistant depression

    Página :3-4

    P.J. Cowen

    Resumen Resumen Esquema Esquema

• Symposia

  • ·An overview of the antidepressant properties of transcranial magnetic stimulation

    Página :4-4

    T.E. Schlaepfer, M. Kosel, C. Frick-Schröter, H.-U. Fisch

    
  • ·Vagus nerve stimulation: a potential new treatment for treatment resistant depression?

    Página :4-4

    A. Zobel, J. Wellmer, N. Freymann, W. Maier

    
  • ·The German Network Research on Schizophrenia

    Página :4-4

    W. Gaebel, W. Wölwer

    
  • ·The Swedish HUBIN Project on Schizophrenia

    Página :4-5

    O. Sedvall, R. Adolfsson, I. Agartz, S. Arnborg, B. Ekholm, H. Hall, E. Jonsson, T.F. McNeil, G. Okugawa, U. Osby, M.J. Owen, L. Terenius

    Resumen Resumen Esquema Esquema

• Symposia

  • ·The Italian Network for Research on Deficit Schizophrenia

    Página :5-5

    S. Galderisi, G.B. Cassano, G. Invernizzi, A. Rossi, M. del Zompo, M. Maj

    
  • ·European First Episode Schizophrenia Trial (EUFEST)

    Página :5-5

    R.S. Kahn

    
  • ·Loss of control and depression

    Página :5-5

    H.-J. Möller

    
  • ·The consequences of loss of control in animal models

    Página :5-6

    F.A. Henn

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Helplessness and stress related conditions in societies and populations of transition

    Página :6-6

    W. Rutz

    
  • ·Loss of control and cardiovascular morbidity

    Página :6-6

    M. Kopp

    
  • ·Depression and cardiovascular morbidity

    Página :6-6

    M. Deuschle

    
  • ·Feasibility and usefulness of routine outcome assessment: the South-Verona Outcome Project

    Página :6-6

    M. Ruggeri, A. Lasalvia, R. Dall'Agnola, M. Tansella

    
  • ·A comparison of needs assessed by staff and by an epidemiologically representative sample of patients with psychosis

    Página :6-6

    G. Thornicroft, M. Slade, M. Phelan

    
  • ·Issues in the routine measurement of quality of life outcome

    Página :6-7

    P. Huxley

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Impact of regular outcome assessment on treatment - the MECCA Study

    Página :7-7

    S. Priebe, J. Bullenkamp, R. McCabe, L. Hansson, W. Roessler, F. Torres-Gonzalez, D. Wiersna

    
  • ·Estimating treatment effects from trials and observational studies

    Página :7-7

    G. Dunn

    
  • ·PET and SPECT in psychiatry

    Página :7-7

    A. Catafau

    
  • ·PET studies of depression

    Página :7-7

    P. Grasby

    
  • ·Dopamine synthesis rate in prefrontal cortex in schizophrenia by use of PET

    Página :7-7

    L. Lindström, O. Gefvert, T. Lundberg, B. Lanullgström

    
  • ·PET and antipsychotic drugs - background

    Página :7-8

    A.-L. Nordström, M. Talvik, C. Halldin, L. Farde

    Resumen Resumen Esquema Esquema

• Symposia

  • ·PET and antipsychotic drugs - future

    Página :8-8

    J. Tedroff, A. Carlsson

    
  • ·Developmental pathogenesis of personality disorder

    Página :8-8

    J. Livesley

    
  • ·Personality - different genes or differences in gene activation?

    Página :8-8

    J. Hallman, H. Garpenstrand, M. Damberg, L. Oreland

    
  • ·Genetics and suicidal behaviour

    Página :8-9

    M. Anullsberg, G. Rylander

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Treatment outcome of personality disorders

    Página :9-9

    P. Tyrer

    
  • ·Anatomy of substance P and NK1 receptors in the brain

    Página :9-9

    T. Hökfelt

    
  • ·Pharmacology - a historical overview

    Página :9-9

    E. Brodin

    
  • ·Diminished anxiety - and depression-related behaviors in substance P-deficient mice

    Página :9-9

    A. Bilkei-Gorzo, I. Radz, A. Zimmer

    
  • ·Substance P (NK1) receptors in mood disorders and schizophrenia

    Página :10-10

    P.W.J. Burnet, P. Harrison

    
  • ·Clinical update: substance P antagonists in patients with major depression

    Página :10-10

    M.S. Kramer

    
  • ·NK-1 receptor antagonists: a review of preclinical and clinical data

    Página :10-10

    P. Chappell, M. Bachinsky, P. Seymour, J. Siuciak, D. Tingley, C. Schmidt, S. McLean

    
  • ·Obstetric complications and schizophrenia - a meta-analysis of population-based studies

    Página :10-10

    M. Cannon, P.B. Jones, R.M. Murray

    
  • ·How identical are monozygotic twins? An fMRI study on language lateralization

    Página :11-11

    I.E.C. Sommer, N.F. Ramsey, D. Graafmans, R.C.W. Mandl, R.S. Kahn

    
  • ·Obstetric complications and risk for first admission with schizophrenia: a Danish national register based study

    Página :11-11

    M. Byrne, E. Agerbo, W.W. Eaton, P.B. Mortensen

    
  • ·Fetal growth impairment - the relevance to psychiatric outcome

    Página :11-11

    C.M. Hultman, S. Cnattingius, P. Sparén, P. Lichtenstein

    
  • ·Minor physical anomalies: moving to the next phase of research

    Página :11-11

    B.D. Kelly, O. McTigue, A. Kinsella, M. Clarke, E. O'Callaghan, C. Larkin, A. Lane

    
  • ·A half-century of neurotransmitter research: impact on neurology and psychiatry

    Página :12-12

    A. Carlsson

    
  • ·Welcome and opening remarks

    Página :12-12

    R.M. Murray

    
  • ·Neuroplasticity

    Página :12-12

    M. Spitzer

    
  • ·Acute psychosis in clinical setting

    Página :12-12

    A. Young

    
  • ·Acute agitation: new treatments

    Página :12-12

    P. Wright

    
  • ·Compliance, cognition and psychosis: first episode

    Página :12-12

    R. Keefe

    
  • ·Acute treatment in Eastern Europe

    Página :12-12

    N. Sartorius

    
  • ·Quality of life and health outcomes: what really matters

    Página :12-12

    M. Knapp

    
  • ·Chairman's address: Novel treatments - a promise fulfilled?

    Página :12-12

    R.M. Murray

    
  • ·Exploring cognition and frontal lobe disorders

    Página :12-12

    R.J. van den Bosch

    
  • ·Taking the patient's view

    Página :12-12

    A. Berntsson

    
  • ·Gene-environment interplay in relation to emotional and behavioural disturbance

    Página :13-13

    M. Rutter

    
  • ·Definitions and boundaries of forensic psychiatry

    Página :13-13

    L. Carpel

    
  • ·Forensic psychiatry is an integral part of general psychiatry

    Página :13-13

    H. Gordon

    
  • ·Forensic psychiatry as a subspecialty of psychiatry

    Página :13-13

    P. Silfen

    
  • ·The German approach to the subspeciality Forensic Psychiatry

    Página :13-13

    H. Sass

    
  • ·Training and education in forensic psychiatry - examining the Israeli model

    Página :13-13

    J. Margolin, M. Kalian

    
  • ·Drug metabolism of nortriptyline and consequences of metabolic drug effects

    Página :13-14

    C. Nordin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Drug metabolism of antipsychotics and clinical consequences

    Página :14-14

    P. Baumann, D. Zullino, C.B. Eap

    
  • ·Clinical pharmacogenetic aspects of thymo- and neuroleptic drug treatment

    Página :14-14

    M.-L. Dahl

    
  • ·Pharmacogenomics, pharmacogenetics and drug response

    Página :14-14

    T. Lewander

    
  • ·Pharmacokinetic drug interactions of new psychotropic agents

    Página :14-14

    E. Spina

    
  • ·Pharmacotherapy of female hypoactive sexual desire disorder

    Página :15-15

    R.T. Segraves

    
  • ·Pharmacotherapy of sexual arousal disorders

    Página :15-15

    R. Balon

    
  • ·Pharmacotherapy - orgasm disorders

    Página :15-15

    M. Waldinger

    
  • ·Female hypoactive sexual desire disorder psychological treatment

    Página :15-15

    K.B. Segraves

    
  • ·Pharmacotherapy of sexual dysfunction in special populations

    Página :15-16

    Z. Zemishlany

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Recent evidence on the neurodevelopmental model of schizophrenia

    Página :16-16

    J. Parnas

    
  • ·Clinical and cognitive markers of the development of schizophrenia

    Página :16-16

    M. Byrne, B. Clafferty, R. Cosway, E. Grant, A. Hodges, H. Whalley, S. Lawrie, D.G. Cunningham-Owens, B.C. Johnstone

    
  • ·Structural and functional MRI in the Edinburgh high risk study

    Página :16-16

    S.M. Lawrie, H. Whalley, D. Job, K.P. Ebmeier, D.G.C. Owens, E.C. Johnstone

    
  • ·An MRI study of subjects in the prodromal phase of psychosis

    Página :16-17

    P. McGuire, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, L.J. Philips, A.R. Yung, E.T. Bullmore, W. Brewer, B. Soulsby, P. Desmond, C. Pantelis

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Disordered brain development and abnormal connectivity

    Página :17-17

    E.T. Bullmore

    
  • ·Evidence based treatments for anorexia nervosa

    Página :17-17

    J. Treasure

    
  • ·Evidence based treatment for bulimia nervosa

    Página :17-17

    H. Wijbrand Hoek

    
  • ·Osteopenia and bone mass increase in adolescent anorexia nervosa

    Página :17-18

    J. Castro Fornieles

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Genes, environment, and eating disorders: Twin study findings

    Página :18-18

    A. Keski-Rahkonen, A. Rissanen, J. Kaprio, R.J. Rose

    
  • ·Somatic consequences of eating disorders

    Página :18-18

    T. Bruna

    
  • ·Swedish support to the restructuration of psychiatry in Eastern Europe

    Página :18-18

    L. Jacobsson

    
  • ·Reforming psychiatry in Eastern Europe - the WHO perspective

    Página :18-18

    W. Rutz

    
  • ·Reforming psychiatric services in Bosnia Hercegovina after the war

    Página :18-19

    S. Loga

    Resumen Resumen Esquema Esquema

• Symposia

  • ·The role of NGOs in mental health reform example - Romania

    Página :19-19

    B. Tudorache

    
  • ·Analysis of obstacles for effective mental health reform in Lithuania

    Página :19-19

    D. Puras

    
  • ·Subcortical vascular dementia: introduction and clinical picture/diagnosis

    Página :19-19

    A. Wallin, M. Jonsson, M. Sjögren

    
  • ·Subcortical vascular dementia: neuropathological findings

    Página :19-19

    D.G. Munoz

    
  • ·Subcortical vascular dementia: cerebrospinal fluid determinations

    Página :20-20

    M. Sjögren, M. Jonsson, A. Wallin

    
  • ·Subcortical vascular dementia: pathophysiology experimental models

    Página :20-20

    L. Pantoni, V. Palumbo, C. Sarti

    
  • ·Subcortical vascular dementia. Therapeutic issues

    Página :20-20

    T. Del-Ser

    
  • ·The relationship between workplace characteristics and health: a comprehensive meta-analysis

    Página :20-20

    B. Faragher, C. Cooper, M. Cass

    
  • ·Job stress-related depression - a Swedish epidemic?

    Página :21-21

    Anullke Nygren, M. Anullsberg, G. Rylander, I. Rydmark, L. Nathell

    
  • ·Burnout links to corporate culture and work group climate

    Página :21-21

    J. Lindell, C.G. Sandberg

    
  • ·Pathophysiological aspects on stress related depression and ischemic heart disease

    Página :21-22

    P. Währborg

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Prevention of work-related stress and ill health: options and obstacles

    Página :22-22

    L. Levi

    
  • ·Dynamics of working memory in schizophrenia

    Página :22-22

    N.F. Ramsey, J.M. Jansma

    
  • ·Sensory information processing in schizophrenia: effect of atypical medications as monitored by fMRI

    Página :22-23

    F.A. Henn, G. Ende, D.F. Braus

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Executive functions in schizophrenia

    Página :23-23

    E.M. Weiss, A. Hofer, W.W. Fleischhacker

    
  • ·FMRI and cognitive dysfunctions in schizophrenia

    Página :23-23

    R. Schlösser, H. Sauer

    
  • ·The influence of antipsychotic treatment on cortical activations in patients with schizophrenia using functional magnetic resonance imaging

    Página :23-23

    T. Sharma, V. Kuman

    
  • ·Genome-wide expression analysis reveals dyregulation of myelination-related genes in chronic schizophrenia

    Página :24-24

    Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, J.D. Buxbaum, V. Haroutunian, A.A. Fienberg

    
  • ·The use of the microarray-technology in schizophrenia

    Página :24-24

    P. Falkai, A. Poustka

    
  • ·Serotonin receptor gene expression in the pathology of schizophrenia

    Página :24-24

    P.W.J. Burnet, S. Eastwood, S. East, N. Crossland, P. Harrison

    
  • ·Glutamate system gene expression in schizophrenia

    Página :24-24

    J.R.W. Deakin, C.T. Toro, A.J. Law

    
  • ·Neuropeptide gene expression in psychiatric subjects

    Página :24-25

    Y. Hurd

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Oligodendroglial reduction in the prefrontal cortex in schizophrenia

    Página :25-25

    N.A. Uranova, D.D. Orlovskaya, V.M. Vostrikov, V.I. Rachmanova

    
  • ·The diagnosis and management of bipolar disorder: developments and controversies

    Página :25-25

    M. Maj

    
  • ·Anxiety

    Página :25-25

    J. Zohar

    
  • ·Decreasing suicide in schizophrenia: the intersept study

    Página :26-26

    H.Y. Meltzer

    
  • ·Criminality of mentally ill patients in general psychiatry

    Página :26-26

    R. Müller-Isberner

    
  • ·Why do some persons with schizophrenia commit crimes?

    Página :26-26

    S. Hodgins, A. Tengström

    
  • ·An international comparison of the profiles of forensic psychiatric patients given first and second-generation antipsychotic medications

    Página :26-26

    M. Eronen

    
  • ·Preventing recidivism among schizophrenic patients with a history of crime

    Página :27-27

    R. Freese, U. Hiscoke, S. Hodgins

    
  • ·Using urine and hair to assess drug and medication use in mentally ill patients

    Página :27-27

    R. Kronstrand

    
  • ·Gender differences in the prevalence of affective disorders

    Página :27-27

    J. Angst, A. Gamma, V. Ajdacic-Gross, D. Eich, W. Rössler

    
  • ·Gender differences in first episode schizophrenia

    Página :27-27

    H. Häfner

    
  • ·Gender, marital status and quality of life in schizophrenia

    Página :28-28

    R.K.R. Salokangas, T. Honkonen, E. Stenganullrd, A.-M. Koivisto

    
  • ·Gender differences in anxiety disorders

    Página :28-28

    H.-U. Wittchen

    
  • ·Women and dementia

    Página :28-28

    J. Kornhuber, J. Wiltfang

    
  • ·Polysomnographic, neuroendocrine and psychometric risk factors for depression

    Página :28-28

    S. Modell, M. Ising, C. Lauer, F. Holsboer

    
  • ·Data from the biomed european consortium for affective disorders

    Página :28-29

    D. Souery, J. Mendlewicz

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Identifying genes for bipolar disorder on chromosome 22 using a convergent functional genomics approach

    Página :29-29

    J.R. Kelsoe

    
  • ·Identification of a bipolar disorder susceptibility gene locus on chromosome 12

    Página :29-29

    N. Barden

    
  • ·Chromosomal abnormalities and depression

    Página :29-30

    D. Blackwood, W. Muir, D. McIntyre, B. Pickard

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Genes and environment in ADHD

    Página :30-30

    A. Thapar

    
  • ·The role of personality in influencing genetic and environmental risk factors for major depression

    Página :30-30

    A. Farmer

    
  • ·Genetic influences on autism

    Página :30-30

    M. Rutter

    
  • ·What do comorbidity studies with somatic disorders tell us about the etiology of schizophrenia?

    Página :30-30

    O. Mors

    
  • ·Genetic and non-genetic factors in bipolar affective disorder

    Página :30-31

    H. Ewald

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Neuroanatomy, neurophysiology and neuropathology of OCD

    Página :31-31

    F. Hohagen

    
  • ·Psychopharmacological treatment in severe and/or resistant OCD: Augmentation strategies

    Página :31-31

    E.-G. Hantouche, J.F. Allilaire

    
  • ·Capsulotomy, a valid treatment for extreme OCD?

    Página :31-31

    S. Andréewitch, C. Rück, K. Flyckt

    
  • ·Deep brain stimulation in severe treatment refractory OCD

    Página :31-32

    P. Cosyns, L. Gabriëls, B. Nuttin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Epidemiology of schizophrenia

    Página :32-32

    P.B. Mortensen

    
  • ·Toxoplasma infection in schizophrenia

    Página :32-32

    R.H. Yolken

    
  • ·Persistent RNA viruses and nervous system dysfunctions

    Página :32-32

    K. Kristensson

    
  • ·Endogenous retroviruses and schizophrenia

    Página :32-32

    H. Karlsson, J. Schröder, S. Bachmann, R.H. Yolken

    
  • ·Depression and Borna disease virus (BDV)

    Página :32-32

    L. Bode, D.E. Dietrich, H. Ludwig

    
  • ·Amantadine treatment in neuropsychiatric disorders with BDV infection

    Página :32-33

    D.E. Dietrich, L. Bode, C.W. Spannhuth, T. Gödecke-Koch, H. Ludwig, H.M. Emrich

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Opioid genes in the actions of drugs of abuse: perspectives from human and experimental animal models

    Página :33-33

    Y. Hurd

    
  • ·Gene expession in addictive disorders

    Página :33-33

    M.J. Kreek

    
  • ·Microarray analysis of brain gene expression in human alcoholism

    Página :33-33

    R.A. Harris, R.D. Mayfield, J. Lewohl, P. Dodd

    
  • ·From phenotype to genes and back: a functional genomics approach to alcohol dependence

    Página :33-34

    M. Heilig, W. Sommer, R. Rimondini, C. Arlinde

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Measurement of somatisation: a cross-cultural perspective

    Página :34-34

    A. Janca

    
  • ·The epidemiology of somatization

    Página :34-34

    P. Fink

    
  • ·The significance of stress in the development of fibromyalgia syndrome

    Página :34-34

    U.M. Anderberg

    
  • ·The immune pathophysiology of fibromyalgia and somatoform disorders

    Página :35-35

    M. Maes, A. Janca, W. Rief

    
  • ·Hypochondria and cognitive therapy

    Página :35-35

    I. Wilhelmsen

    
  • ·Epidemiology and primary-care oriented interventions for somatoform disorders

    Página :35-35

    W. Rief

    
  • ·The Lundby Study - fifty years of psychiatry

    Página :35-35

    P. Nettelbladt, M. Bogren, E. Hofvendahl, C. Mattisson, P. Toranullker, L. Öjesjö, O. Hagnell

    
  • ·Longitudinal study on depression in the elderly

    Página :35-35

    A. Beekman

    
  • ·Depression from middle age to old age. A 32-year follow-up of women

    Página :35-36

    S. Pálsson, L. Larsson, E. Tengelin, M. Waern, S. Samuelsson, T. Hällström, R. Dahlgren, N. Beckman, M. Levander, I. Skoog

    Resumen Resumen Esquema Esquema

• Symposia

  • ·A 15-year follow-up on psychotic symptoms in the non-demented elderly

    Página :36-36

    S. Östling, I. Skoog

    
  • ·A 40-year follow-up of patients with obsessive compulsive disorder

    Página :36-36

    I. Skoog, G. Skoog

    
  • ·Longitudinal study on neurotic disorders in the elderly

    Página :36-36

    J. Copeland

    
  • ·Osteoporosis in young patients with schizophrenia

    Página :36-37

    W.W. Fleischhacker, P. Malik, R. Gasser, R.M. Naveda, M. Hummer

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Sexual side effects lead to low quality of life and non-compliance

    Página :37-37

    J. Gerlach

    
  • ·Schizophrenia and diabetes mellitus

    Página :37-37

    K. Melkersson

    
  • ·Risk of sudden death and putative contributing factors during antipsychotic treatment

    Página :37-37

    J. Reilly

    
  • ·The epidemiological basis for rehabilitation in schizophrenia

    Página :37-37

    P. Munk-Jørgensen

    
  • ·Rehabilitation with focus on cognitive training

    Página :37-38

    L. Lundin

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Work rehabilitation

    Página :38-38

    K.T. Mueser

    
  • ·Interventions for tomorrow

    Página :38-38

    I.-M. Wieselgren

    
  • ·The neurobiology of dopamine signaling

    Página :38-38

    P. Greengard

    
  • ·First episode schizophrenia: a targeted treatment approach

    Página :38-38

    L. Kopala

    
  • ·Chronic symptoms of schizophrenia: improving the outlook

    Página :38-39

    J. van Os

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Long-term treatment benefits: a lesson from the past

    Página :39-39

    A. David

    
  • ·Treatment delivery: a hope for the future

    Página :39-39

    M. Eerdekens

    
  • ·Exploring the pharmacology of enantiomeric drugs

    Página :39-39

    J. Arnt

    
  • ·Escitalopram - progression in antidepressant therapy

    Página :39-39

    S. Montgomery

    
  • ·Increasing the efficacy of antidepressant therapy without compromising the tolerability

    Página :39-39

    A. Wade

    
  • ·Escitalopram - in the treatment of mood and anxiety disorders

    Página :40-40

    D. Baldwin

    
  • ·Job-stress, exhaustion and depression

    Página :40-40

    M. Anullsberg

    
  • ·Neuroprotective effector mechanisms of estrogens

    Página :40-40

    H. Vedder, J.-C. Krieg

    
  • ·Estrogen effects in schizophrenia - brief update and potential therapeutic implications

    Página :40-40

    A. Riecher-Rössler

    
  • ·Hypoestrogenism in schizophrenic women: implications for research

    Página :41-41

    N. Bergemann

    
  • ·Estrogen therapy in women with depression

    Página :41-41

    J. Bitzer

    
  • ·Cerebrospinal fluid estradiol and -amyloid levels in female patients with Alzheimer's disease

    Página :41-41

    P. Schönknecht, J. Pantel, C. Klinga, M. Jensen, T. Hartmann, K. Beyreuther, J. Schröder

    
  • ·Psychosis after childbirth

    Página :41-42

    A. Wieck

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Hormones and mental disorders - focus on estrogen-serotonin interactions

    Página :42-42

    G. Fink

    
  • ·Estrogen - a possible role in the treatment of schizophrenia?

    Página :42-42

    J. Kulkarni

    
  • ·Future perspectives of gender hormones in neuroprotection

    Página :42-42

    H. Ehrenreich, A. Heyer, A.-L. Siren

    
  • ·Gender differences in the genetics of anxiety disorders

    Página :42-42

    J. Deckert

    
  • ·Treating psychiatric symptom with TMS

    Página :43-43

    K.P. Ebmeier, A. McIntosh, D. Semple, D.C. Owens, E.C. Johnstone

    
  • ·Magnetic seizure induction for the treatment of major depression

    Página :43-43

    T.E. Schlaepfer, H.S. Lisanby, H.-U. Fisch, H.A. Sackeim

    
  • ·Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?

    Página :43-43

    M.E. Keck, T. Welt, M.B. Müller, A. Post, I. Sillaber, F. Holsboer

    
  • ·Slow rTMS in major depression and schizophrenia. Review of studies and implications for future research

    Página :43-44

    E. Klein, B. Kaplan, A.V. Chystiakov

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Transcranial magnetic stimulation and depression

    Página :44-44

    T.G. Bolwig

    
  • ·Transcranial magnetic stimulation as a tool for assessment and modulation of cortical excitability in patients with major depression

    Página :44-44

    A.V. Chistyakov, B. Kaplan, H. Häfner, D. Koren, M. Feinsod, E. Klein

    
  • ·Neuromuscular abnormalities in psychosis; implications for nosology, neurodevelopment and neurotransmitter abnormalities

    Página :44-44

    H.Y. Meltzer

    
  • ·Muscle histopathology in schizophrenia

    Página :45-45

    K. Borg, L. Flyckt, G. Edman, T. Ansved, L. Bjerkenstedt, F.-A. Wiesel

    
  • ·Aberrant fingertapping and electromyographical abnormalities in patients with schizophrenia

    Página :45-45

    L. Flyckt, K. Borg, J. Borg, O. Sydow, G. Edman, L. Bjerkenstedt, F.-A. Wiesel

    
  • ·EMG responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

    Página :45-45

    B.K. Puri, N. Davey

    
  • ·The iceberg of obsessive-compulsive syndromes

    Página :45-45

    J. Angst, A. Gamma, V. Ajdacic-Gross, D. Eich, W. Rössler

    
  • ·The art of screening OCD in psychiatry and primary care

    Página :46-46

    E.-G. Hantouche

    
  • ·Prevalence of OCD in resistant and chronic depression

    Página :46-46

    J.-P. Olié

    
  • ·Screening hidden juvenile OCD

    Página :46-46

    F. Kochman, E.-G. Hantouche, H. Akiskal

    
  • ·Phenomenology and treatment of complex OCD: at the interface of bipolarity and psychosis

    Página :46-47

    H.S. Akiskal

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Research collaboration in a post-disaster setting: experience from Nicaragua

    Página :47-47

    G. Kullgren, T. Caldera, L. Palma

    
  • ·Developing research competency - examples from Southeast Asia

    Página :47-47

    E. Hauff

    
  • ·The Butajira Study - a comprehensive Ethiopian study on mental disorders

    Página :47-47

    A. Alem, T. Shibre, D. Kebede, G. Kullgren, L. Jacobsson

    
  • ·Title still to come

    Página :47-47

    I. Levar

    
  • ·Ethics of research collaboration with developing countries

    Página :47-47

    L. Jacobsson

    
  • ·Possibilities and limitations of DTI: a methodological introduction

    Página :48-48

    E. Formisano

    
  • ·DTI in neuropsychiatric disorders

    Página :48-48

    K.O. Lövblad

    
  • ·Abnormal brain white matter in schizophrenia: a diffusion tensor study

    Página :48-48

    I. Agartz, J. Andersson, S. Skare

    
  • ·DTI in hallucinating schizophrenic patients

    Página :48-48

    D. Hubl

    
  • ·Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from DTI

    Página :48-48

    T. Klingberg

    
  • ·Treatment and management of the somatizing patients -introduction

    Página :48-48

    A. Lundin

    
  • ·Treatment of patients with functional gastro-intestinal disorders

    Página :48-48

    F. Creed

    
  • ·Treatment of chronic fatigue syndrome: why not?

    Página :48-48

    M. Sharpe

    
  • ·Cognitive/behavioral treatment of hypochondriasis

    Página :49-49

    A. Barsky

    
  • ·Cognitive-behavioral therapy for the treatment and prevention of chronic pain

    Página :49-49

    S.J. Linton

    
  • ·Behavioural phenotypes

    Página :49-49

    L.M.G. Curfs, S. Tuinier, W.M.A. Verhoeven

    
  • ·Psychopathology in mentally retarded patients

    Página :49-49

    W.M.A. Verhoeven, S. Tuinier, A.E.S. Sijben

    
  • ·Dual diagnosis in trisomy-21

    Página :49-50

    S. Tuinier, W.M.A. Verhoeven

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Neuroanatomy and psychopathology of co-morbid learning disability and schizophrenia

    Página :50-50

    E.C. Johnstone, G.A. Doody, D.G.C. Owens, T. Sanderson

    
  • ·Mice lacking CCK2 receptors display reduced anxiety in the plus-maze

    Página :50-50

    E. Vasar, S. Raud, A. Veraksits, K. Rünkorg, T. Matsui, M. Bourin, C.J. Greengrass, V. Volke, S. Köks

    
  • ·Natriuretic peptides modulate the psychometric and endocrine effects of cholecystokinin tetrapeptide in man

    Página :50-50

    M. Kellner, H. Jahn, D. Naber, K. Wiedemann

    
  • ·Cholecystokinin-serotonin interactions

    Página :50-51

    J. Shlik, C. Nordin, I. Sjödin, T. Gunnarsson, E. Maron, I. Töru

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Cholecystokinin and anxiety disorders

    Página :51-51

    J. Bradwejn, D. Koszycki

    
  • ·Cholecystokinin in cerebrospinal fluid

    Página :51-51

    T. Gunnarsson

    
  • ·Pentagastrin, anxiety and personality

    Página :51-51

    D. Radu, A. Anullhlin, P. Svanborg, N. Lindefors

    
  • ·Current and future treatments for dementia

    Página :51-51

    B. Winblad, V. Jelic

    
  • ·State-of-the-Art in treating alcohol problems

    Página :52-52

    M. Berglund

    
  • ·The non-developmental causes of schizophrenia

    Página :52-52

    R.M. Murray

    
  • ·Women as refugees

    Página :52-52

    S. Anton

    
  • ·Women's mental health in late life. Experience in Bihor

    Página :52-53

    N. Tataru, A. Dicker

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Transcultural aspects of women's mental health - a view from India and Denmark

    Página :53-53

    S.K. Jha

    
  • ·Human rights abuses against women

    Página :53-53

    S. Dahl

    
  • ·Migration and Islamic culture in relation to women's mental health

    Página :53-53

    M. Hofecker Fallahpour

    
  • ·The concept of positive symptoms from a psychopathological point of view

    Página :53-53

    M. Musalek

    
  • ·Conceptualisation of negative symptoms

    Página :53-53

    G. Stanghellini

    
  • ·Neurocognitive dimensions characterizing first-time psychotic patients

    Página :54-54

    S. Friis, K. Sundet, B.R. Rund, P. Vaglum, T.H. McGlashan

    
  • ·Relationship between positive, negative and cognitive symptoms

    Página :54-54

    S. Opjordsmoen, S. Friis, U. Haahr, T.K. Larsen, T. McGlashan, I. Melle, B.R. Rund, E. Simonsen, P. Vaglum

    
  • ·Mapping positive and negative symptoms using brain imaging

    Página :54-54

    G. Sedvall

    
  • ·Cognitive therapy for bipolar disorders

    Página :54-55

    J. Scott

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Cognitive therapy in relapse prevention in unipolar depression

    Página :55-55

    E. Paykel

    
  • ·Cognitive behaviour therapy versus pharmacotherapy in unipolar depression

    Página :55-55

    M. Hautzinger

    
  • ·Interpersonal psychotherapy in depression

    Página :55-55

    C.B. Pull, M.-C. Pull

    
  • ·Perceiving the self in schizophrenia: Abnormalities in the awareness of action

    Página :55-56

    S.-J. Blakemore

    Resumen Resumen Esquema Esquema

• Symposia

  • ·The cognitive neuropsychiatry of self perception

    Página :56-56

    A. David

    
  • ·Aspects of the connection between external tasks and internal processing modalities in patients suffering from schizophrenia

    Página :56-56

    B. Gallhofer

    
  • ·Misattribution of action in schizophrenic patients with Schneiderian symptoms

    Página :56-56

    M. Jeannerod

    
  • ·Schizophrenia conceived as self-disorders

    Página :56-56

    C. Scharfetter

    
  • ·Synaptic proteins in schizophrenia: a bottom-up approach to neural connectivity

    Página :56-56

    W.G. Honer

    
  • ·Introduction and presentation of the activities of the UEMS section & board of psychiatry

    Página :56-56

    A. Lindhardt

    Resumen Resumen Esquema Esquema  
  • ·Recommendations on quality assurance

    Página :57-57

    K.-O. Svärd

    
  • ·Training in psychiatry in Europe from a perspective of the UEMS

    Página :57-57

    A. Lindhardt

    
  • ·CME

    Página :57-57

    M. Gomez-Beneyto

    
  • ·From emergency activities to integrated pre-emergency, emergency and post-emergency programmes

    Página :57-57

    W. Rutz

    
  • ·Reconciliation requires generations - the German example

    Página :57-57

    M. von Cranach

    
  • ·The impact of terror on human mind

    Página :57-57

    G. Tocilj-Simonkovic

    
  • ·The mental health programme and the challenges in Bosnia-Hercegovina

    Página :57-57

    B. Lagerkvist, L. Jacobsson, M. Djeric, N. Mehic-Basara, N. Savjak

    
  • ·Community mental health and psychiatric hospitals: what strategies for reform. The Kosovar and Albanian examples

    Página :58-58

    L. Urbina

    
  • ·Mental health in a divided society

    Página :58-58

    F. Agani

    
  • ·International collaboration and support in the mental health programme in Macedonia

    Página :58-58

    H. Wahlberg

    
  • ·Quality assurance for randomisation and survey instruments in the EDEN-Study

    Página :58-58

    T.W. Kallert, M. Schützwohl, S. Priebe, A. Kiejna, J. Raboch, P. Nawka

    
  • ·Clinical and sociodemographic features of randomised patients in the EDEN-centres

    Página :58-59

    J. Raboch, A. Howardova, J. Hamplova, N. Bakova, M. Sekot, L. Starkova, T.W. Kallert

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Psychopathology and social disabilities of day-hospital and inpatients during acute treatment

    Página :59-59

    A. Kiejna, K. Szajowski, J. Rymaszewska, J. Jarosz-Nowak, T. Kallert

    
  • ·Burden on relatives comparing treatment in inpatient and day-hospital settings

    Página :59-59

    M. Schützwohl, T.W. Kallert, C. Matthes

    
  • ·Subjective evaluation criteria in the EDEN-study

    Página :59-59

    S. Priebe, R. McCabe, A. Okine, D. Wright, T. Kallert

    
  • ·Attitudes towards psychiatric genetics in the Weimar Republic

    Página :59-60

    H. Fangerau, F. Illes, I. Müller, W. Maier, M. Rietschel

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Attitudes towards genetic research in psychiatry

    Página :60-60

    J. Hauser

    
  • ·The attitudes of Turkish psychiatrists towards the genetics of mental illnesses

    Página :60-60

    M. Saylan, S. Cakir, D. Yilmaz, O. Yazici

    
  • ·Informed consent, confidentiality and ethical votes - experience from a multinational psychiatric genetic study

    Página :60-60

    S. Brewster

    
  • ·The legal protection of biotechnological inventions

    Página :60-60

    C. Koenig, E.-M. Müller

    
  • ·Dimensional versus categorical models of psychosis: is there any definitive evidence?

    Página :60-61

    M.J. Cuesta, V. Peralta, S. Eraso, T. Goikoa, A.F. Militino, M.D. Ugarte

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Evidence that three dimensions of psychosis have a distribution in the general population

    Página :61-61

    N. Stefanis, M. Hanssen, N. Smirnis, D. Avramopoulos, I. Evdokimidis, H. Verdoux, J. van Osl, C. Stefanis

    
  • ·Schizotypy and neurocognitive deficits in a non-clinical population

    Página :61-61

    N. Stefanis, N. Smyrnis, D. Avramopoulos, I. Evdokimidis, C. Stefanis

    
  • ·Antisaccade and smooth eye pursuit in a sample of 2000 young males

    Página :61-61

    N. Smyrnis, N. Stefanis, I. Evdokimidis, T. Constantinidis, D. Avramopoulos, C. Stefanis

    
  • ·Developmental instability in schizotypy and psychosis

    Página :61-62

    A. Rosa, L. Fañanás

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Pas de titre

    Página :62-62

    
  • ·Molecular biology of memory and its disorders

    Página :62-62

    E.R. Kandel

    
  • ·Introduction to health economics:terminology and concepts - types of economic evaluations. Choice perspective. Cost components. Markov models

    Página :62-62

    L. Jönssen

    
  • ·Ethical aspects - who should have the right to treatment

    Página :62-62

    S. Thelander

    
  • ·Health economic evaluations in schizophrenia

    Página :62-62

    M. Knapp

    
  • ·Welcome and introduction

    Página :62-62

    L. Farde

    
  • ·Schizophrenia: a chronic illness seeking a long-term solution

    Página :62-62

    R.S. Kahn

    
  • ·Stabilizing the dopamine-serotonin system: a new goal in the management of schizophrenia

    Página :62-62

    L. Farde

    
  • ·Antipsychotic effect and clinical benefit in the management of schizophrenia

    Página :62-62

    M. Bourin

    
  • ·Safety, tolerability and compliance in the use of antipsychotics

    Página :62-62

    W.W. Fleischhacker

    
  • ·Schizophrenia

    Página :63-63

    E.C. Johnstone

    
  • ·Moving from perinatal psychiatry to mental health

    Página :63-63

    A. Coen

    
  • ·Treatments for postnatal unipolar depression: a disorder of the brain and mind

    Página :63-63

    J.L. Cox

    
  • ·Group therapy for mothers with depression

    Página :63-63

    M. Hofecker Fallahpour, C. Zinkernagel Burri, B. Stöckli, G. Wüsten, R.-D. Stieglitz, A. Riecher-Rössler

    
  • ·Title still to come

    Página :63-63

    C. Hornstein

    
  • ·Health care for mentally ill mothers - current status in Austria

    Página :64-64

    C.M. Klier, B. Schmid-Siegel, A. Kumpf-Tontsch, M. Muzik, G. Lenz

    
  • ·Early temperament and development in adolescence

    Página :64-64

    M. Pitzer, M. Laucht, M. Schmidt, G. Esser

    
  • ·Childhood and adolescence predictors of early adulthood conduct problems

    Página :64-64

    M.H. Schmidt

    
  • ·Development and psychopathology in adolescence: findings from the Zurich Adolescence Psychology and Psychopathology Study (ZAPPS)

    Página :64-64

    H.-C. Steinhausen, C. Winkler-Metzke

    
  • ·Parental major depression and prospective longitudinal risks for psychopathology from adolescence to young adulthood in their children: a community study

    Página :64-65

    H.-U. Wittchen, R. Lieb, R.U. Ruhl

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Long-term outcome and prognosis of childhood-OCD

    Página :65-65

    T. Jans, C. Wewetzer

    
  • ·Bipolar disorders - relation to personality and temperament

    Página :65-65

    P. Brieger, A. Marneros

    
  • ·Anxiety and bipolar disorder

    Página :65-65

    G. Perugi

    
  • ·Genetic epidemiology of bipolar disorder

    Página :65-66

    M. Preisig

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Mixed affective and schizoaffective disorders: a challenge for research

    Página :66-66

    A. Marneros, S. Röttig, P. Brieger

    
  • ·The treatment of bipolar disorder

    Página :66-66

    E. Vieta

    
  • ·Genetics and suicidal behaviour

    Página :66-66

    M. Anullsberg, G. Rylander

    
  • ·Serotonergic disturbances in the prefrontal cortex of suicidal patients: implications for treatment and prevention

    Página :66-67

    C. van Heeringen, K. Audenaert

    Resumen Resumen Esquema Esquema

• Symposia

  • ·The stress-system and suicidal behaviour

    Página :67-67

    L. Träskman-Bendz, B. Pendse, Anull. Westrin

    
  • ·UK legislation on analgesic pack sizes: impact on suicidal behaviour

    Página :67-67

    K. Hawton, E. Townsend

    
  • ·Efficacy of St. John's wort extract WS® 5570 in major depression - a double-blind, placebo-controlled trial

    Página :67-67

    Y. Lecrubier, G. Clerc, R. Didi, M. Kieser

    
  • ·Increased levels of D₃ dopamine receptor mRNA in blood lymphocytes of schizophrenic patients

    Página :67-68

    S. Fuchs

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Roles of the D3 receptor and brain-derived neurotrophic factor in behavioural sensitisation to psychomotor stimulants

    Página :68-68

    O. Guillin, N. Griffon, J. Diaz, P. Carroll, J.C. Schwartz, P. Sokoloff

    
  • ·The functions of dopamine D₃ receptors: their pharmacology and potential therapeutic applications

    Página :68-68

    J.J. Hagan

    
  • ·Potential clinical applications of BP 897, a partial dopamine D₃ agonist

    Página :68-69

    J.-C. Schwartz

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Eye movement disturbances and dopamine D3 receptor gene

    Página :69-69

    J.K. Rybakowski, A. Borkowski, P. Czerski, J. Hauser

    
  • ·Information technology and future society

    Página :69-69

    K. Olausson

    
  • ·Using Internet in clinical and epidemiology studies

    Página :69-69

    J.-E. Litton

    
  • ·Treatment of mental disorders via the Internet

    Página :69-70

    G. Andersson, P. Carlbring, L. Strom, V. Kaldo-Sandström, L. Ekselius

    Resumen Resumen Esquema Esquema

• Symposia

  • ·What can Internet add to psychiatry?

    Página :70-70

    N. Lindefors

    
  • ·Internet strategies for AEP

    Página :70-70

    C.B. Pull, J.M. Cloos

    
  • ·deCODE genetics

    Página :70-70

    K. Stefanson

    
  • ·Computer-based characterization of phenotypes for genetic and pharmacogenetic studies in psychiatry

    Página :70-70

    H. Fangerau, T.G. Schulze, F. Illes, S. Ohlraun, D.J. Müller, W. Maier, M. Rietschel

    
  • ·Genetic databases

    Página :70-71

    C. Wahlestedt

    Resumen Resumen Esquema Esquema

• Symposia

  • ·HUBIN - Human Brain Informatics: a database project on schizophrenia

    Página :71-71

    H. Hall, T. McNeil, S. Arnborg, L. Terenius, G. Sedvall

    
  • ·A brain database: architectonics, receptors, functional imaging

    Página :71-71

    K. Zilles, K. Amunts, S. Geyer, A. Schleicher, H. Mohlberg

    
  • ·Sleep physiology and behavior

    Página :71-71

    T. Anullkerstedt

    
  • ·Sleep disturbances in depression

    Página :71-71

    M. Berger

    
  • ·Sleep in schizophrenia

    Página :72-72

    B. Appelberg

    
  • ·Sleep and neuroendocrinology

    Página :72-72

    A. Steiger

    
  • ·Sleep in anxiety disorders and stress

    Página :72-72

    J. Hetta

    
  • ·Exploring antidepressant mechanisms by acute and chronic sleep effects

    Página :72-72

    S.J. Wilson, S. Argyropoulos, J. Nash, J.A. Hicks, C.E. Bel, D.J. Nutt

    
  • ·Pro

    Página :73-73

    S. Wessely

    
  • ·Con

    Página :73-73

    W. Maier

    
  • ·Long term management of depression

    Página :73-73

    E.S. Paykel

    
  • ·A differential approach to intervention in early psychosis

    Página :73-73

    M. Hambrecht, S. Ruhrmann, M. Wagner, A. Wieneke, A. Bechdolf, W. Maier, J. Klosterkötter

    
  • ·The development of the first episode of schizophrenia and depression - a population controlled study

    Página :73-73

    H. Häfner, K. Mauer

    
  • ·Is prediction of psychosis in the general population feasible?

    Página :74-74

    M.S.S. Hanssen, M. Bak, R. Bijl, W. Vollebergh, J. van Os

    
  • ·Findings from the AESOP Study

    Página :74-74

    P.B. Jones

    
  • ·The development of psychosis in the Edinburgh High Risk Study

    Página :74-74

    S.M. Lawrie, P. Miller, R. Cosway, H. Whalley, D.G.C. Owens, E.C. Johnstone

    
  • ·Finding from psycho-pharmaco-epidemiological studies: implications and critical questions

    Página :74-74

    M.-B. de Chouly de Lenclave, D. Bailly

    
  • ·Empirical guidelines for the use of antidepressants in childhood depressive disorders

    Página :74-74

    D. Purper-Ouakil

    
  • ·Selective serotonin re-uptake inhibitor discontinuation syndrome in children and adolescents

    Página :74-74

    L. Tamam

    
  • ·New strategies in ADHD treatment

    Página :74-74

    M.P. Bouvard

    
  • ·Atypical antipsychotic drugs in childhood onset schizophrenia

    Página :74-75

    T. Mozes, S. Tyano

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Aberrant tyrosine transport across the cell membrane in schizophrenia

    Página :75-75

    F.-A. Wiesel, L. Flyck, N. Venizelos, G. Edman, L. Bjerkenstedt, L. Hagenfeldt

    
  • ·Fatty acid composition of membranes in psychiatric patients

    Página :75-75

    J. Assies, R. Lieverse

    
  • ·Increased lipid peroxidation in schizophrenia; a marker of membrane breakdown?

    Página :75-75

    O. Akyol

    
  • ·Phospholipid metabolism and schizophrenia: new clinical trials

    Página :75-76

    M. Peet

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Phospholipid metabolism and depression: new clinical trials

    Página :76-76

    D.F. Horrobin

    
  • ·Hippocampal atrophy on MRI in the diagnosis of Alzheimer's disease

    Página :76-76

    E.S.C. Pelgrim-Korf, P.H. Scheltens

    
  • ·Total-tau, A _1-42 and Ubiquitin in CSF in the diagnosis of Alzheimer disease

    Página :76-76

    K. Iqbal

    
  • ·CSF tau phosphorylated at threonine 231, total tau and neuronal thread protein in the diagnosis of Alzheimer's disease

    Página :77-77

    H. Hampel, K. Bürger, R. Zinkowski, S.J. Teipel, R. Kohnken, D. Kerkman, J. DeBernardis, P. Kahle, S.I. Rapoport, T. Sunderland, H. Arai, T. Tapiola, K. Hoffmann-Kiefer, N. Andreasen, K. Blennow, H.-J. Möller, P. Davies

    
  • ·Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer's disease

    Página :77-77

    K. Blennow

    
  • ·A42 plasma in the diagnosis of Alzheimer's disease

    Página :77-77

    M. Riemenschneider

    
  • ·Culture, trauma and refugees

    Página :77-78

    A.J. Marsella

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Caring for survivors of torture

    Página :78-78

    I. Genefke

    
  • ·War trauma in Sarajevo

    Página :78-78

    S. Loga, I. Ceric, E. Music

    
  • ·The Chilean experience

    Página :78-78

    M. Fernandez

    
  • ·The meaning of refugee trauma and recovery during the asylum-waiting process

    Página :78-78

    V. DeMarinis

    
  • ·Basic symptom concept (BSC) and prodromal psychosis

    Página :79-79

    G. Huber

    
  • ·The onset of schizophrenic psychosis

    Página :79-79

    G. Gross

    
  • ·Conceptual problems with early stages of psychosis

    Página :79-79

    M. Heinimaa

    
  • ·The prodromal symptoms of psychosis: experiences from the TOPP clinic

    Página :79-79

    T.K. Larsen, B. Arntzen, N. Helland, I. Joa

    
  • ·Results from Copenhagen prodrome project

    Página :79-79

    J. Parnas

    
  • ·The neurobiology of nicotine dependence and depression: common pathways and mechanisms

    Página :80-80

    D.J. Balfour

    
  • ·Depression and smoking. Cause or consequence?

    Página :80-80

    Y. Lecrubier

    
  • ·New treatments in tobacco dependence

    Página :80-80

    K.O. Fagerström

    
  • ·Neuropsychiatric drug treatments to promote smoking cessation. Present and future

    Página :80-80

    I. Berlin

    
  • ·The programme against stigma and discrimination because of schizophrenia in Spain

    Página :80-80

    J.J. Lopez-Ibor

    
  • ·Crazy? So what!? Effects of a school project on mental health and illness on students' attitudes

    Página :81-81

    B. Schulze, M. Richter-Werling, H. Matschinger, M.C. Angermeyer

    
  • ·The antistigma action programme in Slovakia: a catalyst to integration

    Página :81-81

    P. Nawka, C.M. Reiss, L. Dolobác

    
  • ·On stigma and discrimination of mentally ill - report from a WHO/EURO task force

    Página :81-81

    L. Jacobsson

    
  • ·Neurobiological basics of transfer in brain

    Página :81-81

    B.U. Meyer

    
  • ·Alexithymia and cerebral hemispheres

    Página :81-81

    M. Joukamaa

    
  • ·Alexithymia and lateralized presentation of emotional faces

    Página :82-82

    M.A. Lumley, T. Ovies, K. Curyto, D. Whitman

    
  • ·Interhemispheric transfer in alexithymia

    Página :82-82

    H.J. Grabe, C. Spitzer, C. Willert, T. Rizos, B. Möller, H.J. Freyberger

    
  • ·The relevance of dissociative symptomatology in assessing the interhemispheric transfer

    Página :82-82

    C. Spitzer, C. Wiliert, H.J. Grabe, T. Rizos, B. Möller, H.J. Freyberger

    
  • ·Health is not given - patterns of 12 month somatic and mental disorders comorbidity in the community

    Página :82-82

    H.-U. Wittchen, R. Friis, F. Jacobi, H. Pfister

    
  • ·Schizophrenia, autoimmune diseases and human leucocyte antigens

    Página :82-82

    P. Wright, P. Donaldson, R.M. Murray

    
  • ·Novel antipsychotics and weight gain

    Página :83-83

    A. Magnusson

    
  • ·Depression and ischemic heart disease

    Página :83-83

    C. Sørensen

    
  • ·What explains the increased incidence of schizophrenia in some immigrant groups to the Netherlands?

    Página :83-83

    J.-P. Selten

    
  • ·Evidence that ethnic group effects on psychosis risk are confounded by experience of discrimination

    Página :83-84

    I. Janssen, M. Hanssen, M. Bak, R. Biji, W. Vollebergh, K. McKenzie, J. van Os

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Migration and schizophrenia: a Danish population-based cohort study

    Página :84-84

    E. Cantor-Glaae, C. Bøcker Pedersen, T. McNeil, P.B. Mortensen

    
  • ·Does racial discrimination cause mental illness?

    Página :84-84

    K.J. McKenzie

    
  • ·Social isolation and high rates of psychosis among migrant groups

    Página :84-84

    G. Hutchinson, C. Morgan, R.M. Murray

    
  • ·Experimental psychopathology in personality disorders

    Página :84-85

    S.C. Herpertz, B. Wenning, K. Schnell, T. Dietrich, H. Saß

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Neuropsychological measures in BPD patients and matched controls

    Página :85-85

    A. Andreoli, Y. Burnand, E. Mayer

    
  • ·The implications of behavioural genetic research for concepts and models of personality disorder

    Página :85-85

    J. Livesley

    
  • ·Psychometric approaches in personality research

    Página :85-85

    R. Pukrop

    
  • ·Personality disorders in ICD-10 and DSM-IV

    Página :85-85

    C.B. Pull, M.-C. Pull, J.M. Cloos

    
  • ·Psychiatric education, scientific and research activities in Yugoslavia

    Página :86-86

    D. Duisnullin

    
  • ·Organization, ethical and legal aspects of mental health service in Yugoslavia

    Página :86-86

    T. Cnullavic

    
  • ·Past, present and future in education in psychiatry in Romania

    Página :86-86

    A. Mihai, A. Nirestean

    
  • ·Organisation of psychiatric service in Romania

    Página :86-86

    M. Pop, A. Nirestean, A. Mihai

    
  • ·Novel methods to study brain morphology in schizophrenia

    Página :86-87

    N.C. Andreasen, T. White, P. Nopoulos

    Resumen Resumen Esquema Esquema

• Symposia

  • ·The brain morphology of schizophrenia

    Página :87-87

    P. Falkai

    
  • ·Are brain changes in schizophrenia focal and are they progressive?

    Página :87-87

    R.S. Kahn

    
  • ·Heteromodal association cortex involvement in schizophrenia

    Página :87-87

    T.E. Schlaepfer, G. Pearlson

    
  • ·Time course of structural brain changes in schizophrenia: an update

    Página :87-87

    A. Vita, L. De Peri, M. Dieci

    
  • ·Brain morphometry and auditory hallucinations in schizophrenia

    Página :87-87

    P.W.R. Woodruff

    
  • ·Background and design of the Paternalism and Autonomy' Study

    Página :88-88

    G. Hoyer, M. Engberg, R. Kaltiala-Heino, L. Kjellin, M. Sigurjonsdottir

    
  • ·How valid are statistics on civil commitment rates in the Nordic Countries?

    Página :88-88

    M. Engberg, R. Kaltiala-Heino, O. Hoyer, L. Kjellin, M. Sigurjonsdottir

    
  • ·Measurements of perceived coercion; methodological problems

    Página :88-88

    C. Tuohimäki, R. Kaltiala-Heino, M. Engberg, G. Hoyer, L. Kjellin, M. Sigurjonsdottir, M. Joukamaa

    
  • ·Legal mode of admission and deprivation of liberty in psychiatric care in the Nordic Countries

    Página :88-89

    L. Kjellin, M. Engberg, G. Hoyer, R. Kaltiala-Heino, M. Sigurjonsdottir

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Measurements of perceived coercion; methodological problems

    Página :89-89

    G. Hoyer, C.W. Lidz, M. Engberg, R. Kaltiala-Heino, L. Kjellin, M. Sigurjonsdottir

    
  • ·The role of 5-HT activity in anti-psychotic treatment

    Página :89-89

    V. Bubeniková, J. Horacek, V. Platilová, L. Zavesická, R. Bahbouh, F. Stastný, T. Pálenicek

    
  • ·Brain metabolism (PET) and cognitive performance in schizophrenia

    Página :89-89

    J. Horacek, M. Kopecek, F. Spaniel, L. Zavesicka, O. Belohlavek, D. Janeba

    
  • ·Neuropsychological dysfunctions in the families of schizophrenic patients

    Página :89-89

    A. Borkowska, J.K. Rybakowski

    
  • ·Computer-assisted rehabilitation of cognitive functions in schizophrenia

    Página :89-90

    M. Rodriguez, M. Preiss, P. Mohr

    Resumen Resumen Esquema Esquema

• Symposia

  • ·Cognitive-behavioral therapy to promote smoking cessation

    Página :90-90

    H.-J. Aubin

    
  • ·Health hazards by smokeless tobacco use

    Página :90-90

    G. Bolinder

    
  • ·A community reinforcement approach for smoking cessation

    Página :90-90

    F. Poldrugo, C. Porpat, G.L. Montina, F. Pivotti

    
  • ·International guidelines for smoking cessation - an overview

    Página :91-91

    A. Batra

    
  • ·Pas de titre

    Página :91-91

    
  • ·The fetus and external agents

    Página :91-91

    I. Krägeloh-Mann

    
  • ·Alcohol and neurotrophic factors during pregnancy

    Página :91-91

    E. Halmesmäki

    
  • ·Excitatory and inhibitory neuroreceptors: their role for the fetal alcohol syndrome

    Página :91-91

    S. Liljequist

    
  • ·Alcohol and the developing organism - fetus, child and youth

    Página :92-92

    U. Rydberg

    
  • ·Background factors and consequences of teenage alcohol consumption

    Página :92-92

    P.-A. Rydelius

    
  • ·From specialist training to continuing medical education in Italy

    Página :92-92

    F. Perris, A. Fiorillo

    
  • ·Training in psychiatry in France. A national survey among psychiatric trainees

    Página :92-92

    C. Hanon, D. Mathis, T. Gallarda, H. Loo

    
  • ·Psychiatry training in Belgium and the European Training Charter

    Página :93-93

    J. Vandenberghe

    
  • ·Prevailing status, training procedure and future perspectives of psychiatry in Turkey

    Página :93-93

    O. Ozturk, B. Burcu

    
  • ·2 grades, 2 exams, 6 specialties; psychiatric training: UK & Ireland

    Página :93-93

    A.J. Lloyd

    Resumen Resumen Esquema Esquema  
  • ·Longitudinal study of recently resettled refugees

    Página :93-93

    H.P. Söndergaard

    
  • ·Decreased level of cortisol and testosterone among massevacuated adults from Kosovo with trauma experiences and diagnosis of PTSD

    Página :94-94

    G. Roth

    
  • ·The impact of torture on post-traumatic stress symptoms in massevacuated from Kosovo

    Página :94-94

    S. Ekblad

    
  • ·Caregivers' encounter with somatic communication of mental ill health in a multicultural community

    Página :94-94

    S. Bäämhielm, S. Ekblad

    
  • ·National Swedish introduction programme for refugees - a programme with a potential for mental health promotion

    Página :94-94

    F. Lindencrona

    

• Posters, Sunday, 5 May 2002

  • ·Gender differences according to clinical effects of antidepressant treatment

    Página :95-95

    M. Grubbe Goetke, E.W. Steyerberg, K.B. Stage, J. Passchier, P. Kragh-Sørensen, J.T. Larsen

    
  • ·Citalopram efficacy in PAD and OCD disorders

    Página :95-95

    G. Tavormina

    
  • ·Bright light therapy as an antidepressant modality

    Página :95-95

    G. Tavormina

    
  • ·Age-related differences in the side effect profile of citalopram

    Página :95-96

    Y. Barak, M. Swartz, R. Weizman

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Antidepressant remeron in the treatment of alcoholism

    Página :96-96

    N.N. Ivanets, T.V. Agibalova

    
  • ·Lithium augmentation in venlafaxine non-responders: an open study

    Página :96-96

    G. Bertschy

    
  • ·Antidepressant and anxiolytic effect of St. John's wort extract ZE-117

    Página :96-96

    M. Friede, J. Freudenstein

    
  • ·Efficacy and tolerability of mirtazapine in HIV-1 infected outpatients

    Página :96-96

    J. Blanch, J. de Pablo, G. Masana, A. Miñarro, A. Villarroya, A. Rousaud, J.M. Gatell, C. Gastó

    
  • ·Mega-analysis of sertraline vs. fluoxetine in major depression

    Página :97-97

    M. Flament, J. Gillespie

    
  • ·Moclobemide in early poststroke depression: an open study

    Página :97-97

    A. Kasperowicz-Dabrowiecka, E. Wanat-Slupska, M. Ziolkowska-Kochan, B. Ksiazkiewicz, A. Araszkiewicz

    
  • ·Placebo-controlled efficacy comparison of escitalopram and citalopram

    Página :97-97

    J. Gorman

    
  • ·Escitalopram prevents relapse of depressive episodes

    Página :97-97

    M.H. Rapaport, A. Bose, H. Zheng

    
  • ·Age specificity in the psychopharmacotherapy of endogenous depressions in adolescence

    Página :97-98

    I.V. Oleichik, V.V. Artioukh, A.M. Etingof, T.V. Vladimirova

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Glucocorticoid Receptor-mRNA levels are regulated in human blood cells by different types of antidepressants

    Página :98-98

    H. Vedder, A. Heiske, S. Fischer, J.-C. Krieg

    
  • ·Duloxetine 60 mg QD is efficacious in the treatment of depression

    Página :98-98

    M. Detke, I. Bitter, Y. Lu, D. Goldstein, M. Demitrack

    
  • ·Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

    Página :98-98

    D. Goldstein, I. Bitter, Y. Lu, M. Detke, C. Wiltse, C. Mallinckrodt, M. Demitrack

    
  • ·Olanzapine-fluoxetine combination in treatment-resistant depression

    Página :98-98

    S. Dube, S. Paul, T. Sanger, L. Van Campen, S. Corya, G. Tollefson

    
  • ·Antidepressants of the different chemical groups: clinical and neurophysiological correlations in treating depression

    Página :99-99

    E. Grigorieva, A. Dyakonov

    
  • ·Coadministration of clozapine and amisulpride in psychotic patients

    Página :99-99

    M. Ziegenbein, O. Rosenthal, P. Garlipp

    
  • ·Characteristics of acute schizophrenic patients on atypical antipsychotics

    Página :99-99

    V.P. Kontaxakis, B.J. Havaki-Kontaxaki, C.T. Kollias, M.M. Margariti, S.S. Stamouli, G.N. Christodoulou

    
  • ·Cognitive function in stable outpatients switched to ziprasidone

    Página :99-100

    P.D. Harvey, H.Y. Meltzer, S.J. Romano

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Ziprasidone vs olanzapine for cognitive function in schizophrenia

    Página :100-100

    P.D. Harvey, G. Simpson, R. Horne, P.J. Weiden, M. Bari, S.J. Romano

    
  • ·Health status indices in stable outpatients switched to ziprasidone

    Página :100-100

    P.J. Weiden, D.G. Daniel, G. Simpson, S.J. Romano

    
  • ·Therapeutic response in stable outpatients switched to ziprasidone

    Página :100-100

    P.J. Weiden, G. Simpson, S.G. Potkin, S.J. Romano

    
  • ·Ziprasidone vs haloperidol for IM/oral therapy of acute schizophrenia

    Página :100-101

    S. Brook, W. Jorge, I. Benattia

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·The outpatient treatment with olanzapine of a 24-year-old male patient suffering from acute psychosis

    Página :101-101

    L. Muzinic-Masle, M. Herceg, E. Koic, V. Djordjevic, S. Vondracek

    
  • ·No weight gain among demented patients after 1 year of risperidone

    Página :101-101

    J. Rabinowitz, Y. Barak, L. Paanakker

    
  • ·Ziprasidone's long-term efficacy and tolerability in schizophrenia

    Página :101-101

    H.Y. Meltzer

    
  • ·Ziprasidone vs olanzapine in schizophrenia: a double-blind trial

    Página :101-102

    G. Simpson, R.L. Horne, P.J. Weiden, T. Pigott, M. Bari, S.J. Romano

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Recent weight gain and cost of acute service use in schizophrenia

    Página :102-102

    P.J. Weiden, J.A. Mackell, D.D. McDonnell

    
  • ·Application of rispolept at heroin addiction in outpatient practice

    Página :102-102

    A. Kozlov

    
  • ·Patient attitude after switch to ziprasidone from other antipsychotics

    Página :102-102

    A.G. Awad, L. Vourganti, A. Dugar

    
  • ·Aripiprazole and risperidone versus placebo in schizophrenia

    Página :102-103

    P. Yeung, R.D. McQuade, W.H. Carson, A. Saha, M.W. Ali, G. Ingenito

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Increased rates of antipsychotic-induced eps in mania: myth or reality

    Página :103-103

    P. Cavazonni, P.H. Berg, R.W. Baker, A. Evans, M. Tohen

    
  • ·Controlled study of aripiprazole and haloperidol in schizophrenia

    Página :103-103

    S. Anutosh, M.W. Ali, G. Ingenito, W.H. Carson

    
  • ·Ziprasidone vs ainisulpride for negative symptoms of schizophrenia

    Página :103-103

    J.-P. Olié, E. Spina, I. Benattia

    
  • ·Aripiprazole: a dopamine-serotonin system stabilizer

    Página :103-103

    T. Kilcuchi, K.D. Burris, S. Jordan, R.D. McQuade

    
  • ·Smooth and safe transition from intramuscular to oral olanzapine

    Página :104-104

    P. Wright, K. Meehan, M. Birkett, S.R. David, C.C. Taylor, P. Morris, A. Breier

    
  • ·Risperidone and quetiapine for treatment-resistant schizophrenia

    Página :104-104

    P. Polana, E. Roveyaz, A. Colotto

    
  • ·Neurocognitive effects: aripiprazole vs olanzapine in stable psychosis

    Página :104-104

    R.S. Kern, B. Cornblatt, W.H. Carson, E. Stock, A.R. Saha, M.W. Ali, G. Ingenito, M.F. Green

    
  • ·Calming versus sedative effects of IM olanzapine in agitated patients

    Página :104-105

    S.R. David, J. Battaglia, K.L. Alaka, K. Meehan, P. Wright

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·QTc intervals: IM olanzapine treatment in acutely agitated patients

    Página :105-105

    M. Tohen, S.R. David, C.M. Beasley, K. Alaka

    
  • ·Risperidone and olanzapine in inpatient treatment of bipolar disorder

    Página :105-105

    A. Mehnert, M. Jones

    
  • ·Atypical antipsychotics in schizophrenia and mood disorder

    Página :105-105

    A. Mehnert, M. Jones

    
  • ·Meta-analysis of the efficacy of aripiprazole in schizophrenia

    Página :105-105

    W.H. Carson, E. Stock, A.R. Saha, M.W. Ali, R.D. McQuade, M.J. Kujawa, G. Ingenito

    
  • ·Safety and tolerability meta-analysis of aripiprazole in schizophrenia

    Página :106-106

    W.H. Carson, E. Stock, A.R. Saha, M.W. Ali, R.D. McQuade, M.J. Kujawa, G. Ingenito

    
  • ·Risperidone monotherapy in secondary prophylaxis of affective and schizoaffective disorders

    Página :106-106

    G.M. Granenov, E.G. Kostiukova, S.N. Mosolov

    
  • ·Atypical antipsychotics in Parkinson's disease organic psychosis

    Página :106-106

    T. Sobow, M. Gorczowski

    
  • ·New antipsychotics in acute psychosis with spontaneous dyskinesia

    Página :106-106

    D. Marcinko, I. Filipcic, M. Jakovljevic

    
  • ·Amisulpride vs olanzapine in schizophrenia. Preliminary results on short-term analysis

    Página :107-107

    O. Fleurot, S. Martins, H. Loo, J. Peuskens, W. Rein

    
  • ·Patient and observer perspectives on venlafaxine ER efficacy in GAD

    Página :107-107

    E. Salinas, B. Pitrosky, D. Hackett

    
  • ·Do baseline gastrointestinal symptoms alter venlafaxine ER efficacy?

    Página :107-107

    R.B. Lydiard, B. Pitrosky, D. Hackett, C. White

    
  • ·Duration of treatment with venlafaxine ER in GAD

    Página :107-107

    P.T. Ninan, D. Hackett, V. Haudiquet

    
  • ·Construct validity of affective temperament questionnaire: data from the National French Study EPIDEP

    Página :108-108

    E.-G. Hantouche, J.F. Allilaire, H.S. Akiskal

    
  • ·Pure versus dysphoric mixed mania: 12-month prospective follow-up data from the French National EPIMAN Study

    Página :108-108

    J.M. Azorin, E.-G. Hantouche, J.F. Allilaire, M. Bourgeois, D. Sechter, S. Lancrenon, L. Châtenet-Duchêne, H.S. Akiskal

    
  • ·Frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France

    Página :108-108

    M. de Zelicourt, R. Dardennes, H. Verdoux, G. Gandhi, E.T. Edgell, F. Fagnani

    
  • ·Olanzapine cotherapy in prevention of recurrence in bipolar disorder

    Página :109-109

    M. Tohen, K.N.R. Chengappa, T. Suppes, R.W. Baker, R.C. Risser, A.R. Evans, J.R. Calaberse

    
  • ·Olanzapine versus divalproex sodium for bipolar mania: a 47-week study

    Página :109-109

    M. Tohen, R.W. Baker, L. Altshuler, C.A. Zarate, T. Suppes, T.A. Ketter, R.C. Risser, E. Brown, M.F. Luther, J.A. Gilmore, L. Schuh

    
  • ·Case report of 5 bipolar disorder patients (Rapid Cycling) followed for 3 years, treated with lamotrigine

    Página :109-109

    S.A. Asghar

    
  • ·The bipolar spectrum disorders: implications for new drug development

    Página :109-110

    J. Kogeorgos

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Obstetric complications as risk factors for bipolar disorder

    Página :110-110

    B. Kirk Øgendahl, R.W. Licht, P.B. Mortensen

    
  • ·A diffusion tensor and metabolite spectroscopic imaging study of white matter connectivity in schizophrenia

    Página :110-110

    J.K. Burns, M. Bastin, S. Lawrie, I. Marshall, T. McGillivrary, H. Whalley, D. Job, E. Johnstone

    
  • ·Magnetic resonance tomography (MRT) of brain of serial sexual sadists

    Página :110-110

    O.A. Bukhanovskaya, A.O. Bukhanovsky

    
  • ·Progression of hippocampal atrophy is associated with clinical deterioration in Alzheimer's disease

    Página :110-111

    P. Schönknecht, J. Pantel, M. Essig, M. Amann, L. Schad, J. Schröder

    Resumen Resumen Esquema Esquema

• Poster, Sunday, 5 May 2002

  • ·MR volumetry during acute alcohol withdrawal and abstinence

    Página :111-111

    I. Agartz, J. Franck, G. Okugawa, K. Svinhufvud, H. Bergman

    
  • ·Reliability and reproducibility of MR brain tissue segmentation

    Página :111-111

    I. Agartz, G. Okugawa, G. Sedvall

    
  • ·Cerebellar vermis volume reduction in patients with chronic schizophrenia

    Página :111-111

    G. Okugawa, G. Sedvall, I. Agartz

    
  • ·Vagus nerve stimulation and fMRI in treatment-resistant depression

    Página :111-111

    Z. Nahas, J.-H. Chae, M. Lomarev, S. Denslow, B. Anderson, R. Kapp, D. Bohning, M. Geroge

    
  • ·An EEG study of visual-sensory integration in schizophrenia

    Página :112-112

    A. Peled, A. Pressman, A. Geva, I. Modai

    
  • ·Effects of VNS on rCBF in patients with treatment-resistant depression

    Página :112-112

    S. Delisi, J. Zajecka, W. Miles, R. Rosenblate, S. Gutierrez, B. Caughran

    
  • ·Metabolic abnormalities of severe, chronic treatment resistant depression post VNS implant

    Página :112-112

    S. Sheikh, F. Abuzzahab, J. Lee, J. Pardo, M. Hagen

    
  • ·Changes in brain metabolism in response to chronic vagus nerve stimulation for depression and association with clinical response

    Página :112-112

    C.R. Conway, J.T. Chibnall, J.W. Fletcher, X. Li, M.S. George

    
  • ·Changes in regional cerebral blood flow in response to acute vagus nerve stimulation in depressed patients and association with clinical response

    Página :113-113

    C.R. Conway, J.T. Chibnall, J.W. Fletcher, X. Li, M.S. George

    
  • ·Trends in BOLD response during processing emotional cues in depression

    Página :113-113

    S. Surguladze, M. Brammer, M. Phillips

    
  • ·Cerebral blood flow in bipolar disorder measured with PET: I trait effects at rest and after mood induction

    Página :113-113

    S. Krüger, K. Goldapple, D. Kennedy, H.S. Mayberg

    
  • ·Effects of VNS on regional cerebral blood flow in depressed subjects

    Página :113-114

    M.D. Devous, M. Husain, T.S. Harris, A.J. Rush

    Resumen Resumen Esquema Esquema

• Poster, Sunday, 5 May 2002

  • ·Auditory event-related potential and PET: functional correlations

    Página :114-114

    M. Emri, T. Glaub, R. Berecz, Z. Lengyel, P. Mikecz, E. Bartok, L. Tron, I. Degrell

    
  • ·Auditory event-related potential and PET

    Página :114-114

    T. Glaub, R. Berecz, M. Emri, A. Fekeshazy, T. Miklovitz, E. Bartok, I. Degrell, L. Tron

    
  • ·Borderline personality disorder by children and teen-agers use of tales in therapy workshops

    Página :114-114

    H. Scharbach

    
  • ·Role of the family during adolescence

    Página :114-115

    N. Zdanowicz, P. Janne, Ch. Reynaert

    Resumen Resumen Esquema Esquema

• Poster, Sunday, 5 May 2002

  • ·Free will and diminished responsibility of adolescents

    Página :115-115

    L.O. Perezhogin

    
  • ·Long-treatment outcomes of adolescent depression with associated anxiety

    Página :115-115

    I. Martsenkovsky, Y. Bikshaeva, I. Martsenkovskaya, A. Druginskaya, M. Rudzinskaya

    
  • ·An open-label study of olanzapine in the first episode of schizophrenia in adolescents

    Página :115-115

    M. Dabokowska

    
  • ·Effectiveness and tolerance of moclobemide in treatment of mood and anxiety disorders in adolescents

    Página :115-115

    M. Dabkowska

    
  • ·Psychological aspects of radiation risk perception by children after Chernobyl

    Página :116-116

    Y. Kolominsky, S. Igumnov, V. Drozdovitch

    
  • ·Lasting armed conflict in Chechnaya and mental health of children

    Página :116-116

    E. Koren

    
  • ·Long-term sertraline treatment for pediatric OCD: remission rates and functional status

    Página :116-116

    E. Cook, K. Wagner, H. Chung, R. Wolkow, M. Messig

    
  • ·Psychopathology among 8 year old Danish children

    Página :116-116

    D. Petersen, N. Bilenberg

    
  • ·Psychiatry and the Viable Fetus: Clinical, Ethical and Legal Issues

    Página :117-117

    K. Kaufman

    
  • ·Violence in school as coping-reactions

    Página :117-117

    G. Butorin

    
  • ·School particularities of depression

    Página :117-117

    N. Butorina

    
  • ·Psychopathology and related predictors in infancy

    Página :117-117

    E. Christiansen, T. Houmann, A.M. Skovgaard, S. Landorph, S.K. Nielsen, K. Heering

    
  • ·Risperidone in children with subaverage IQ and behavior disorders

    Página :118-118

    A. Turgay, R. Snyder, C. Binder, S. Fisman, A. Carrol

    
  • ·Risperidone in children with conduct problems and subaverage IQ

    Página :118-118

    R.L. Findling, M.G. Aman, G. De Smedt, A. Derivan

    
  • ·Risperidone in children with disruptive behaviors and subaverage IQ

    Página :118-118

    R.L. Findling, J.M. Fegert, G. De Smedt

    
  • ·Are the parents of mentally distrubed children and adolescents also disturbed?

    Página :118-118

    M. Pejovic-Milovancevic, S. Popovic-Deusic, O. Aleksic

    
  • ·Aggressive behaviour in adolescents: an open-label study with Quetiapine

    Página :118-119

    L. Bardenstein, A. Kurashov, Y. Mozhginski, V. Posochova

    Resumen Resumen Esquema Esquema

• Poster, Sunday, 5 May 2002

  • ·Self-reported prodromal symptoms of adolescents attending psychiatric care

    Página :119-119

    T. Suomela, M. Heinimaa, T. Ilonen, J. Korkeila, J. Huttunen, T. Ristkari, R.K.R. Salokangas

    
  • ·Premorbid social adjustment and early-onset schizphrenia course

    Página :119-119

    M. Kotlicka-Antczak, A. Gmitrowicz, K. Rabe-Jablonska

    
  • ·Integrated treatment of aggressive child & adolescent inpatients

    Página :119-119

    G.N. Cohen, D. Dispenza, K. Braillier

    Resumen Resumen Esquema Esquema  
  • ·Cortical connectivity disturbances in acute and chronic schizophrenia

    Página :119-120

    V. Borisovna Strelets

    Resumen Resumen Esquema Esquema

• Poster, Sunday, 5 May 2002

  • ·Is critical flicker fusion a trait marker?

    Página :120-120

    F. Cavaglia, F. Simões do Couto, A. Matos-Pires, R. Cabrita, F. Arriaga

    
  • ·Emotion recognition deficit and cognition in schizophrenia

    Página :120-120

    G. Sachs, D. Steger, I. Kryspin-Exner, H. Katschnig

    
  • ·Does antidepressant therapy improve cognitive function in elderly depressed patients?

    Página :120-120

    D. Coffey, T. Oxman, L. Jenkyn, M. Doraiswamy, T. Burt, R. Fayyad, C. Clary

    
  • ·Dementia with delirium caused by vitamin B12 deficiency

    Página :120-120

    V. Lerner, M. Kanevsky

    

• Posters, Sunday, 5 May 2002

  • ·Reliable discrimination of axis II disorders in panic disorder

    Página :121-121

    G. Pérez, M. Cabre, F. Gutierrez, J. Sangorrin, A. Bulbena, R. Martin-Santos

    
  • ·Psychopathological evolution in patients with bladder tumor

    Página :121-121

    A. Matos-Pires, M. Nascimento, L. Paula, D. Pires-Barreira, J. Dias, F. Cavaglia

    
  • ·Heavy cannabis users seeking treatment: prevalence of psychiatric disorders

    Página :121-121

    M. Arendt

    
  • ·Social anxiety and anxiety disorders

    Página :121-121

    O. Zikic, L. Trajanovic, A. Djordjevic, Z. Stevanovic

    
  • ·Hormonal therapy of mental disorders caused by menopause

    Página :121-122

    S. Netrusova

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms

    Página :122-122

    P. Bräunig, S. Krüger, J. Höffler, G. Shugar, I. Börner, J. Langkrär

    
  • ·Fahr syndrome

    Página :122-122

    N. Bjelica, S. Slovakovic, M. Preradovic, Z. Spiric, R. Samardzic

    
  • ·Characteristics of sustained depression in patients with acute coronary syndrome (ACS)

    Página :122-122

    C. Sørensen, A. Brandes, O. Hendricks, J. Thrane, E. Friis-Hasché, T. Haghfelt, P. Bech

    
  • ·Affective disorders in neurological diseases: a register based study

    Página :122-122

    F.M. Nilsson, L.V. Kessing, T.G. Bolwig, T. Møller Sorensen, P.K. Andersen

    
  • ·Experience from the first ACT-programme in Denmark. I. Baseline evaluation

    Página :122-123

    J. Aagaard, Jørgen Achton Nielsen

    Resumen Resumen Esquema Esquema  

• Posters, Sunday, 5 May 2002

  • ·Experience from the first ACT-programme in Denmark. II. Severe mental illness. A register diagnosis

    Página :123-123

    J. Aagaard, Jørgen Achton Nielsen

    
  • ·Experience from the first ACT-programme in Denmark. III. The first 60 patients

    Página :123-123

    J. Aagaard, C.M. Nielsen, M. Hjorth, B. Bang, J.A. Nielsen

    
  • ·Psychiatric service by eyes of the consumers

    Página :123-124

    S. Davidouski

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Mental health service systems in 5 Eastern and Western European regions

    Página :124-124

    T. Kallert, T. Adamowski, A. Okine, N. Bakova, D. Borosova

    
  • ·Structural and procedural characteristics of psychiatric day hospitals in Eastern and Western European countries

    Página :124-124

    T. Kallert, M. Schützwohl, C. Matthes, D. Borosova, A. Howardova, A. Okine, J. Rymaszewska

    
  • ·Immune-receptor-endocrine interactions in the pathophysiology of major depression

    Página :124-124

    S. Minenko

    
  • ·The role of depression in early psychological rehabilitation in patients with CHD

    Página :124-125

    M. Kowalska, J. Tylka, I. Korzeniowska-Kubacka, K. Leszczynska, M. Stepnowska

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Current comorbidity of DSM-IV MDD in the Vantaa depression study

    Página :125-125

    T.K. Melartin, H.J. Rytsala, U.S. Leskela, P.S. Lestela-Mielonen, T.P. Sokero, E.T. Isometsa

    
  • ·Parental separation at birth and depression in adulthood

    Página :125-125

    J. Veijola, P. Maki, M. Joukamaa, H. Hakko, M. Isohanni

    
  • ·Prolactin secretion in response to haloperidol challenge in delusional and non-delusional depression

    Página :125-125

    L. Lykouras, M. Markianos, J. Hatzimanolis, P. Oulis, G.N. Christodoulou

    
  • ·Mitochondrial function in selected major depressive disorder patients

    Página :125-126

    A. Gardner, A. Johansson, R. Wibom, I. Nennesmo, U. von Döbeln, L. Hagenfeldt, T. Hällström

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Stability of Karolinska scales of personality in chronic depression

    Página :126-126

    A. Gardner, T. Hällström

    
  • ·HMPAO-SPECT with computerized brain atlas (CBA) in chronic depression

    Página :126-126

    A. Gardner, M. Pagani, H. Jacobsson, G. Lindberg, S.A. Larsson, A. Wägner, T. Hällström

    
  • ·Clinical aspects of comorbidity of ulcer disease and depressive disorder

    Página :126-126

    T. Zagromova, N. Kornetov, G. Gerlov

    
  • ·Does change in depression status predict change in hrQoL?

    Página :126-127

    M. Amir, S. McKenna, M. Martini, D. Bushnell, D. Whalley, D. Patrick

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Seasonal fluctuations of state of health in Western Siberia

    Página :127-127

    G. Simutkin, N. Kornetov

    
  • ·Prevalence of depression in old patients of social care in Siberia

    Página :127-127

    N. Kornetov, Y. Prudnikova, A. Kornetov

    
  • ·A record-based analysis of 803 patients treated for depression in psychiatric care

    Página :127-127

    H.J. Rytsälä, T. Melartin, U. Leskelä, P. Lestelä-Mielonen, P. Sokero, E. Isometsä

    
  • ·The natural history of late-life depression

    Página :127-127

    R. Schoevers, A. Beekman, D. Deeg, C. Hooije, C. Jonker, W. Van Tilburg

    
  • ·Somatic and psychic presentation of depression in Italian general practice: differences in subjects with comorbid chronic medical conditions

    Página :128-128

    C. Fraticelli, M. Passamonti, M. Pigni

    
  • ·Alexithymia and depression - a one-year follow-up study

    Página :128-128

    S.P. Saarijarvi, J.K. Salminen, T. Toikka

    
  • ·A canonical analysis of self-and observer-rated depression symptoms

    Página :128-128

    V. Haudiquet, D. Hackett

    
  • ·Major depression and return to work - predictive factors

    Página :128-128

    J.K. Salminen, S. Saarijarvi, T. Toikka, R. Raitasalo, J. Tikka

    
  • ·The effects of RS-86 on sleep with respect to depression and HLA-type

    Página :128-129

    S.M. Adena, M.A. Ising, C. Lauer, F. Holsboer, S. Modell

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Therapeutic sleep deprivation in depression: total sleep deprivation versus late partial sleep deprivation, a review of the literature

    Página :129-129

    F. Schwärzler, C. Bernecker, M. Schweinsberg, H. Giedke

    
  • ·Psychology evaluation of patients suffering from nonulcer dyspepsia

    Página :129-129

    S. Tosic-Golubovic, S. Miljkovic, H. Djordjevic, A. Djordjevic, V. Sibinovic, S.R. Sibinovic

    
  • ·The influence of anxiety - depression syndrome on the evolution of COPD

    Página :129-129

    S. Miljkovic, S. Tosic-Golubovic, H. Djordjevic, A. Djordjevic, V. Sibinovic

    
  • ·Psychopathological reactions after mastectomy

    Página :129-129

    H. Djordjevic, S. Tosic-Golubovic, S. Miljkovic, A. Djordjevic, V. Sibinovic

    
  • ·Olanzapine-fluoxetine combination for treatment of psychotic depression

    Página :130-130

    S. Dube, S. Andersen, D. Clemow, T. Sanger, M. Tohen, G. Tollefson

    
  • ·HPA axis activation in patients with few versus multiple episodes of depression

    Página :130-130

    A. Ehnvall, M. Sjögren, O.C.G. Zachrisson, H. Anullgren

    
  • ·Dementia: neuroradiological imaging and neuropsychological testing are useful and necessitive extensions of clinical diagnostics

    Página :130-130

    M. Kreis, M. Damian, B. Krumm, M. Syre, S. Speck, F. Hentschel

    
  • ·Alzheimer's disease diagnostics and the treatment at the psychiatric out-patients department

    Página :130-131

    D. Ignjatovic, M. Ignjatovic

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Intramuscular olanzapine: efficacy and safety in acutely agitated patients with dementia

    Página :131-131

    M. Karena, H. Wang, S. David, J.R. Wright, B. Jones, C.M. Beasley, P. Feldman, A. Breier

    
  • ·The DemTect®: a very sensitive screening instrument for mild dementia

    Página :131-131

    E. Kalbe, J. Kessler, R. Smith, R. Bullock, L. Fischer, P. Calabrese

    
  • ·Efficacy of quetiapine in the treatment of behavioral symptoms in dementia

    Página :131-131

    M.L. Onor, M. Saina, M. De Vanna, E. Aguglia

    
  • ·Cerebrospinal fluid 24S-hydroxycholesterol is increased in Alzheimer's disease compared to healthy controls

    Página :131-131

    P. Schönknecht, J. Pantel, D. Lütjohann, T. Hartmann, K. Beyreuther, J. Schröder

    
  • ·Neurochemical markers in the cerebrospinal fluid in frontotemporal dementia. Relation to other dementia disorders

    Página :132-132

    M. Sjögren

    
  • ·Blood pressure dysregulation and Alzheimer's disease: a case-control study

    Página :132-132

    T. Sobow, I. Kloszewska

    
  • ·Which tests are renunceable in the diagnosis of dementia without relevant losses in discrimination?

    Página :132-132

    M. Damian, M. Kreis, B. Krumm, M. Syren, S. Speck, F. Hentschel

    
  • ·Neuroimaging and frontal-subcortical dysfunction in a stroke cohort

    Página :132-132

    J. Looi, P. Sachdev, M. Valenzuela, H. Brodaty, W. Wen, L. Lorentz, J. Sims, J. Kinch, D. Gillies, R. Schnier

    
  • ·Depression - suicidal ideation - bulimia nervosa

    Página :133-133

    A. Martischnig, A. Lechner, B. Steinbrenner, M. Schönauer-Cejpek, M. Steinbauer

    
  • ·Eating disorders co-morbidity in heroin addicts in MMT

    Página :133-133

    M. Campana, M. Metzger

    
  • ·Leptin and its soluble receptor across the eating disorder spectrum

    Página :133-134

    V. Martiadis, P. Monteleone, V. Iannuzzi, C. Micillo, M. Maj

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Investigation of neuroactive steroids in anorexia and bulimia nervosa

    Página :134-134

    B. Colurcio, P. Monteleone, G. De Filippis, L. De Luca, M. Maj

    
  • ·Leptin production in bulimia nervosa

    Página :134-134

    N. Longobardi, P. Monteleone, A. Tortorella, M. Fabrazzo, M. Maj

    
  • ·Plasma levels of neurosteroids in the binge eating disorder

    Página :134-134

    A. Di Lieto, P. Monteleone, B. Colureio, V. Martiadis, M. Maj

    
  • ·Neuropsychological and neuroendocrine indices in eating disorders

    Página :134-134

    P. Bucci, G. Amati, D. Sorrentino, A. Mucci, S. Galderisi, M. Maj

    
  • ·Attachment styles and cognitive functions in eating disorders

    Página :135-135

    D. Sorrentino, A. Tonni, F. Mancuso, A. Mucci, S. Galderisi, M. Maj

    
  • ·ECT for patients taking lamotrigine

    Página :135-135

    T.F. Aarre, P. Bugge

    
  • ·Education in families with autistic children in comparison

    Página :135-135

    H. Niederhofer

    
  • ·Evaluating a training course for GPs in the management of depression

    Página :135-135

    C. Dixon

    
  • ·Development of communicative skills and self-knowledge of students

    Página :135-136

    T. Nelubova, V. Solozhenkin

    Resumen Resumen Esquema Esquema

• Posters, Sunday, 5 May 2002

  • ·Psychoprophylaxis and health promotion in organic psychic disturbances

    Página :136-136

    W. Gruszczynski, A. Florkowski

    
  • ·Effects of vagus nerve stimulation on sleep in depressed patients

    Página :136-136

    R. Armitage, M. Husain, R. Hoffmann, A.J. Rush

    
  • ·Gender differences in spectral EEG analysis during exacerbation of schizophrenia

    Página :136-136

    W. Drozdz, A. Araszkiewicz, J.K. Rybakowski

    

• Posters, Monday, 6 May 2002

  • ·Unmet needs in persons with long-term psychiatric disabilities

    Página :137-137

    L. Jansson, K. Sonnander, F.-A. Wiesel

    
  • ·Very early separation and criminality

    Página :137-137

    P. Maki, H. Hakko, M. Joukamaa, M. Isohanni, J. Veijola

    
  • ·Prevalence lifetime of substance use and other addictive behaviours in high school students

    Página :137-137

    M. Riglietta, M. Campana

    
  • ·Suicide and schizophrenia: an epidemiological study in the area of Varese, Italy

    Página :137-138

    C. Fraticelli, R. Sutera

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·12-month prevalence of panic disorder in the Swedish general population

    Página :138-138

    P. Carlbring, H. Gustafsson, L. Ekselius, O. Andersson

    
  • ·Suicide risk in relation to socioecomonic, demographic, psychiatric and familial factors

    Página :138-138

    P. Qin, E. Agerbo, P.B. Mortensen

    
  • ·Psychiatric epidemiology and genetics

    Página :138-138

    E. Kringlen

    
  • ·Occupational and industrial differences in anxiety and depression

    Página :138-139

    S. Bjarte, G. Seppola Tell, A. Mykletun

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Dementia and cognitive disorders in an oldest old population: a neuropsychological and genetic study

    Página :139-139

    V. Volterra, I. Faranca, L. Cavrini, S. Ragni, C. Franceschi, M. Bonafè

    
  • ·The temporal association between fatigue and psychiatric morbidity

    Página :139-139

    P. Skapinakis, G. Lewis, V. Mavreas

    
  • ·The study of depression disorders' spreading among the ambulatory patients in Kyrgyzstan

    Página :139-139

    V. Solozhenkin, V. Ten

    
  • ·Treatment of agitation and agressiveness among French elderly residents

    Página :140-140

    P.H. Robert, J.-M. Lerger, N. Rebah, D.A. Gerard

    
  • ·Predictors of alcoholism in sons of alcoholics at age 40

    Página :140-140

    J. Knop, B.C. Penick, P. Jensen, W. Gabrielli, E.J. Nickel, B. Ebdrup

    
  • ·The psychiatrist's duty to protect. How?

    Página :140-140

    A.O. Bukhanovsky, O.A. Bukhanovskaya, A.R. Felthous, R. Gleyzer

    
  • ·Involuntary placement of mentally ill in the European Union - legislation and practice

    Página :140-140

    H. Dreßing, M. Peitz, H.J. Salize

    
  • ·The comparison of forensic-psychiatric traits between female and male perpetrators of murder or attempted murder

    Página :141-141

    L. Muzinic-Masle, M. Goreta, V. Jukic, E. Koic

    
  • ·Factors influencing involuntary psychiatric admissions

    Página :141-141

    V.P. Bozikas, V. Tsipropoulou, M. Bogiatzi, H. Deseri, M.H. Kosmidis, S. Pitsavas, A. Karavatos

    
  • ·The temporal relationship between schizophrenia and crime

    Página :141-141

    R. Munkner, S. Haastrup, P. Kramp, T. Jørgensen

    
  • ·A follow-up of mentally disordered offenders - recidivism and mortality

    Página :141-141

    T. Björk, P. Lindqvist

    
  • ·New legislation in the UK designed to increase public safety - a psychiatric view

    Página :141-142

    P.J.M. Banerjee, S. Geelan

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Two legal indications of compulsory outpatient treatment in Israel

    Página :142-142

    A. Teitelbaum, Y. Bar-El, M. Shlafman, R. Durst

    
  • ·The impact of intensive case management on violent patients with psychosis

    Página :142-142

    E. Walsh, M. Leese, S. Byford, K. Gilvarry, C. Samele, T. Tatten, P. Tyrer, R. Murray, T. Fahy

    
  • ·Involuntary placement of mentally ill in the European Union - admission rates and epidemiology

    Página :142-142

    H.J. Salize, M. Peitz, H. Dreßing

    
  • ·Criminal activity and mentally disordered offenders

    Página :142-142

    S. Tosic-Golubovic, S. Miljkovic, H. Djordjevic, A. Djordjevic, V. Sibinovic

    
  • ·Social anxiety disorders

    Página :143-143

    S. Kasper, H. Loft, J. Smith

    
  • ·A meta-analysis of psychological treatments for GAD

    Página :143-143

    K.G. Götestam, I.-L. Ottesen, A.W. Woldset

    
  • ·Family-based association study of serotonin receptor gene and schizophrenia

    Página :143-143

    V. Golimbet, T. Sherabatikh, V. Kaleda, I. Oleichik, G. Lyashenko, T. Kaidan, T. Genisheva, A. Muratova, E. Rogaev

    
  • ·TNF alpha polymorphism in mothers of schizophrenia patients

    Página :143-143

    F. Rybakowski, P. Czerski, J. Hauser, P. Kapelski, S. Godlewski, J. Rybakowski

    
  • ·HLA antigenes in schizophrenia: relation to eye movement disturbances

    Página :144-144

    A. Borkowska, P. Bogacki, J. Rybakowski

    
  • ·No association between norepinephrme transporter gene (1287 A/G) polymorphism and schizophrenia

    Página :144-144

    A. Leszczynska-Rodziewicz, P.M. Czerski, P. Kapelski, S. Godlewski, M. Dmitrzak-Weglarz, J.K. Rybakowski, J. Hauser

    
  • ·The significance of the hereditary factors in the clinical-nosological differentiation of the schizoaffective psychosis

    Página :144-144

    L. Abramova

    
  • ·The C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene is associated with depression, but not anxiety

    Página :144-145

    I. Bjelland, G.S. Tell, S.E. Vollset, P.M. Ueland, H. Refsum

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Association between major depressive disorder and a specific haplotype of the CRH binding protein gene

    Página :145-145

    S. Claes, J. Del-Favero, D. Souery, J. Mendlewicz, R. Adolfsson, C. Van Broeckhoven

    
  • ·Interleukin-1beta gene promoter polymorphism and risk to functional psychosis

    Página :145-145

    S. Papiol, B. Martín, A. Rosa, B. Gutiérrez, P. Salgado, R. Catalán, C. Gastó, L. Fañanas

    
  • ·Th1 and Th2 relationship in schizophrenia - immunological, immunogenetic and therapeutic investigations

    Página :145-145

    M.J. Schwarz, M. Riedel, H. Kroenig, S. Sokullu, N. Müller, M. Ackenheil

    
  • ·States of loss of sense in late age and their role in creation of lingering depressive responses

    Página :145-146

    Y. Polichtchouk, I. Baranskaya, Z. Letnikova, A. Kolpakov

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Mortality risk in the octo- and nonagenerians: longitudinal results of an epidemiological follow-up community study

    Página :146-146

    I. Meller, M.M. Fichter, H. Schroppel

    
  • ·Psychotic major depression in the elderly and suicidal behaviour

    Página :146-146

    L. Lykouras, R. Gournellis, A. Fortos, P. Oulis, G.N. Christodoulou

    
  • ·The efficacy of specialised old age psychiatric wards: a multicenter randomised clinical trial

    Página :146-146

    T.T.J. Kircher, C. Meisner, F. Schwärzler, G. Buchkremer, H. Wormstall

    
  • ·Huntington's Disease: a relevant diagnosis for geriatic patients?

    Página :146-146

    F. Schwärzler, H. Wormstall

    
  • ·Elderly patients with dementia and psychosis treated with risperidone

    Página :146-147

    G. Gharabawi, F. Grossman

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Psychiatric assessment after hip fractures - possible use of it

    Página :147-147

    M. Pejovic-Milovancevic, V. Randjic, R. Milovancevic

    
  • ·Atypical symptoms in geriatric depression

    Página :147-147

    C. Cimmino, C. Balista, E. Nonis, M. Amore

    
  • ·Psychotic symptoms in geriatric depression

    Página :147-148

    C. Cimmino, C. Balista, C. Franco, E. Nonis, M. Amore

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Onset in elderly depressive patients

    Página :148-148

    C. Cimmino, C. Balista, E. Nonis, M. Amore

    
  • ·Gender differences in geriatric depression

    Página :148-149

    C. Balista, C. Cimmino, E. Nonis, M. Amore

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Guidelines for economic evaluation of treatments for major depression

    Página :149-149

    K. Frasch, N.U. Neumann

    
  • ·The economic burden of schizophrenia in Russia

    Página :149-149

    I. Gurovich, E. Lyubov

    
  • ·Healthcare utilization in patients with treatment resistant depression

    Página :149-149

    J. Russell, E.R. Berndt, S.N. Finkelstein, A.S. Whiter, W.H. Crown

    
  • ·Costs for evidence-based care of patients with schizophrenia

    Página :149-149

    E. Wennström, I.-M. Wieselgren, F.-A. Wiesel

    
  • ·Health care expenditures of patients with major depressive disorder and post traumatic stress disorder

    Página :150-150

    J. Crystal-Peters, S. Chang, S. Long, R. Tretiak

    
  • ·Olanzapine or risperidone treatment initiation: SOHO Study Results

    Página :150-150

    E.T. Edgell, P. Frewer, J.M. Haro, D. Novick, M. Lothgren

    
  • ·Schizophrenia treatment in Europe: country differences in the SOHO Study

    Página :150-150

    J.M. Haro, E.T. Edgell, P. Frewer, D. Novick, M. Lothgren

    
  • ·Baseline results from SOHO: a pan-European, observational study

    Página :150-151

    J.M. Haro, E.T. Edgell, P. Frewer, D. Novick, M. Lothgren

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Hospitalisation and costs for schizophrenia relapse treatment in Germany

    Página :151-151

    A. Spannheimer, U. Reitberger, J. Clouth, M. Lothgren

    
  • ·Economic aspects of bipolar disorder in Europe

    Página :151-151

    A. Lowin, M. Knapp, D. Grant, G. Gandhi, E.T. Edgell

    
  • ·Outcomes and cost's associated with different antipsychotic treatment

    Página :151-151

    E. Lindström, J. Mattila, S. Olsson, H. Arthur, E. Eriksson, B. Larsbro, T. Luostannen, G. Aavik-Nilsson, M. Sjökvist

    
  • ·Is the web-administered CIDI-SF equivalent to a human SCID-interview?

    Página :151-152

    P. Carlbring, P. Forslin, M. Willebrand, P. Ljungstrand, C. Strandlund, L. Ekselius, G. Andersson

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·A clinical database in child and adolescent psychiatry

    Página :152-152

    N. Bilenberg

    
  • ·The IT Child-Centre program - using modern technologies in a field children's mental health

    Página :152-152

    L. Slusnys, E. Karmaza

    
  • ·Psychopathology in patients with chronic renal failure

    Página :152-152

    A. Senturk, L. Tamam, B.A. Levent, A. Arif Koroglu

    
  • ·Creativity and mental disorders

    Página :152-152

    E. Lauronen, J. Veijola, I. Isohanni, P.B. Jones, M. Isohanni

    
  • ·The GAF-Scale's variability in clinical routine work

    Página :153-153

    S. Tungström, P. Söderberg, B.-Anull. Armelius

    
  • ·Sense of control, control modes and adjustment to breast cancer

    Página :153-153

    O. Roiz, M. Amir, M. Koretz

    
  • ·Tokophobia: a morbid dread of childbirth

    Página :153-153

    K. Hofberg, I. Brockington

    
  • ·Mental pathology in homeless people. American and European studies

    Página :153-153

    M. Tronchoni, V. Aparicio, E.G. Castro, M. Noriega

    
  • ·Taking care and treatment in mental health

    Página :153-154

    L. Ferrannini, P. Ciancaglini, P.F. Peloso

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·The increasing importance of psychology in the determination of the ecological problems

    Página :154-154

    V. Durcik, D. Ignjatovic, M. Ignjatovic

    
  • ·Early detection of psychosis in mentally retarded: particularities

    Página :154-154

    F.T.K. Schultze-Lutter

    
  • ·The psychopathological phenotype of Velo-Cardio-Facial Syndrome

    Página :154-154

    W.M.A. Verhoeven, S. Tuinier, A. Vogels, A. Swillen, L.M.G. Curfs, J.P. Frijns

    
  • ·Hyponatremia during carbamazepine therapy in the learning disabled

    Página :154-155

    B. Kelly, J. Hillery

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Risperidone for behavioral disturbances in adults

    Página :155-155

    C.A. Gagiano, S. Read, L. Thorpe, G. De Smedt

    
  • ·Effect of naltrexone on dopamine system functions in morphine dependent rats

    Página :155-155

    I.P. Anokhina, A.G. Veretinskaya, G.N. Vasilieva, I.Y. Shamakina

    
  • ·Autoradiographic localisation of 5-HT receptors in the human brain

    Página :155-155

    K. Varnäs, H. Hall, C. Halldin, G. Sedvall

    
  • ·Evidence for neuroplastic activity in acute schizophrenic psychosis

    Página :155-156

    M. Rothermundt, M. Peters, M. Wiesmann, M. Hettich, S. Abel, S. Rudolf, H. Kirchner, V. Arolt

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Anatomy and function of the Corpus Callosum

    Página :156-156

    A.-S. von Richthofen, M. Voss, B.-U. Meyer

    
  • ·Monaminergic systems in depressed patients with and without suicidal behavior

    Página :156-156

    B. Baumann, H. Bielau, M.W. Agelink, D. Krell, K. Truebner, P. Danos, B. Bogerts

    
  • ·Gender differences in neuronal survival upon hypoxia

    Página :156-156

    A. Heyer, A.-L. Siren, H. Ehrenreich

    
  • ·Endocannabinoids in schizophrenia and other psychiatric disorders

    Página :156-156

    F.M. Leweke, A. Giuffrida, C.W. Gerth, J. Faulhaber, K. Klosterkötter, D. Piomelli

    
  • ·Serum antioxidant capacity in psychiatric, neurological and renal diseases

    Página :157-157

    A. Rustembegovic, G. Kroyer, E. Sofic

    
  • ·A neuropsychological analysis of impaired reality testing

    Página :157-157

    T. Ilonen, T. Cannon, T. Taiminen, H. Karlsson, H. Lauerma, K.-M. Leinonen, E. Wallenius, J. Hietala, R.K.R. Salokangas

    
  • ·Neuropsychological valuation of brain function in schizophrenia families

    Página :157-157

    V. Orlova, N. Tsherbakova, T. Savina, N. Korsakova, I. Ermakov, L. Mikaelyan, T. Likhareva

    
  • ·Cognitive and emotion processing deficits in early dementia

    Página :157-157

    L. Fischer, P. Calabrese, E. Kalbe, J. Kessler

    
  • ·Impaired spatial learning in schizophrenic patients

    Página :158-158

    L. Friege, D. Hoell, R. Ferstl, B. Leplow, J. Aldenhoff

    
  • ·Childhood motor impairment and persistent anxiety in adolescent boys

    Página :158-158

    E. Sigurdsson, J. van Os, E. Fombonne

    
  • ·Neurotrophins in prenatally damaged brain: implications in psychiatry

    Página :158-158

    M. Fiore, A. Iannitelli, G. Bersani, J. Korf, L. Aloe

    
  • ·Mental disorders in the patients with thyroid gland diseases

    Página :158-158

    N. Piatnitski, S. Tsirkin

    
  • ·Blunted prolactin response to fenfluramine following add-on fluvoxamine

    Página :159-159

    H. Silver, N. Inteligato, A. Peled, M. Jabarin, V. Isakov, M. Ritsner, I. Modai, S. Lupovich

    
  • ·Release of prolactin but not of adenocorticotropic hormone increases significantly in lactate-induced panic attacks

    Página :159-159

    C. Otte, M. Kellner, H. Jahn, J. Arlt, K. Wiedemann

    
  • ·Marker of bipolar mania: soluble IL-2 & transferrin receptors in serum

    Página :159-159

    S.-Y. Tsai, H.-C. Lee, C.-C. Chen

    Resumen Resumen Esquema Esquema  
  • ·Neuroplasticity in major depression may be indicated by S100B

    Página :159-159

    V. Arolt, M. Peters, M. Rothermundt

    
  • ·Word recognition memory in healthy subjects at risk for depression

    Página :159-160

    D.E. Dietrich, A. Klockow, U. Hauser, W. Nager, H.M. Emrich

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Graft schemes for the treatment of various mental diseases

    Página :160-160

    I.V. Ermakova

    
  • ·Addiction and functional brain asymmetry

    Página :160-160

    M. Chuhrova, V. Leutin, N. Stepushina, G. Kovalevskaya

    
  • ·Changes in visual evoked potentials after magnesium in anxiety disorders

    Página :160-160

    E. Libigerova, D. Gayer, J. Kremlacek, I. Tuma, J. Chlubnova, J. Libiger

    
  • ·Stimulus processing and behavior control in schizophrenic patients

    Página :160-160

    M. Schubert, C.J. Fischer, G. Fritzer, N. Stafe, M.R. Lemke

    
  • ·Effect of astrocyte grafts on the audiogenic seizures in Wistar rats

    Página :161-161

    A. Sidorenkov, I. Ermakova, N. Lermontova

    
  • ·Usage of derivatives of D-glucosamine in emotional hypertension due to stress

    Página :161-161

    I.I. Kanurnyy

    
  • ·Brief obsessive compulsive scale (BOCS)

    Página :161-161

    S. Bejerot

    
  • ·Whole blood tryptophan predicts paroxetine/clomipramine outcome in OCD

    Página :161-161

    M. Humble, P.B.F. Bergqvist, S. Bejerot

    
  • ·Acute effect of deep brain stimulation on psychopathology in OCD

    Página :162-162

    L. Gabriëls, P. Cosyns, B. Nuttin

    
  • ·Attention/executive control systems hyperactivity in OCD

    Página :162-162

    U. Volpe, G. Piegari, E. Merlotti, A. Mucci, S. Galderisi, M. Maj

    
  • ·Factors influencing treatment choice in panic disorder with agoraphobia

    Página :162-162

    V. Starcevic, E.H. Uhlenhuth, D. Kolar, M. Latas

    
  • ·Combination of benzodiazepines and SSRI in treatment of panic disorder

    Página :162-162

    M. Latas, V. Starcevic, G. Trajkovic, D. Vucinic

    
  • ·Pindolol in panic disorder

    Página :163-163

    M. Ziegenbein, A. Steiger, H. Murck

    
  • ·Panic disorder with agoraphobia and marital functionality

    Página :163-163

    B. Batinic, M. Pejovic, M. Marjanovic

    
  • ·Personality disorders a main risk for panic disorder

    Página :163-163

    D.-M. Podea

    
  • ·Hypobaric hypoxia is effective in anxiety disorders

    Página :163-163

    A. Atamanov

    
  • ·Magnetic resonance imaging as precipitating factor for the development of panic attack and possibility of pre-medication with paroxetin

    Página :163-164

    D. Ignjatovic, M. Ignjatovic, V. Durcik

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Differential diagnostics of panic disorder and following treatment of the psychiatric policlinic

    Página :164-164

    M. Ignjatovic, D. Ignjatovic

    
  • ·Hypochondriasis or pseudo? Relationship with anxiety and its treatment

    Página :164-164

    O.R. Carrion, G. Bustamante, R. Mileo

    
  • ·Comparison of paroxetine and reboxetine in panic disorder

    Página :164-164

    G. Migliarese, D. Di Pasquale, C. Michele, A. Bertani, B. Laura, P. Giampaolo

    
  • ·Paroxetine and respiration in panic disorder: preliminary results

    Página :164-164

    M. Cucchi, D. Di Pasquale, A. Bertani, D. Caldirola, L. Bellodi, G. Perna

    
  • ·Respiratory irregularity in respiratory subtype panic

    Página :165-165

    D. Caldirola, M. Cucchi, A. Bertani, G. Migliarese, S. Biffi, L. Bellodi, G. Perna

    
  • ·Effects of venlafaxine on CO2 hyperreactivity in panic disorder

    Página :165-165

    D. Di Pasquale, R. Bussi, G. Migliarese, A. Bertani, L. Bellodi, G. Perna

    
  • ·The language of dyspnea in panic disorder

    Página :165-165

    C. Namia, M. Cucchi, S. Biffi, A. Bertani, G. Perna

    
  • ·Treatment of panic disorder via the Internet: two randomized trials

    Página :165-165

    P. Carlbring, B. Westling, P. Ljungstrand, L. Ekselius, G. Andersson

    
  • ·Comorbidity in panic disorders

    Página :165-166

    F. Romosan

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·A naturalistic fifteen-year follow-up study of panic disorder patients

    Página :166-166

    S. Andersch, J. Hetta

    
  • ·Pathomorphosis of histrionic personality disorder

    Página :166-166

    L.O. Perezhogin, O.V. Rasponomareva

    
  • ·Psychosis proneness scales and DSM schizophrenia spectrum personality disorders

    Página :166-166

    A. Laurent

    
  • ·Behavior control after induction of emotion in borderline personality disorder

    Página :166-166

    C.J. Fischer, T. Wendorff, M.R. Lemke

    
  • ·The process of mentalisation in borderline

    Página :166-167

    E. Messini, E. Papastathopoulos, A. Theodorou, O. Gasparatou, M. Angelopoulou, E. Paliokosta

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Clinically significant subgroups of borderline personality disorder (PD)

    Página :167-167

    S. Karterud, G. Pedersen

    
  • ·Personality disorders after traumatic brain injury

    Página :167-167

    S. Koponen, T. Taiminen, R. Portin, L. Himanen, H. Isoniemi, H. Heinonen, S. Hinkka, O. Tenovuo

    
  • ·Informant's report of defense mechanisms in depression

    Página :167-167

    M. Bronnec, E. Corruble, M. Reynaud, J.D. Guelfi, P. Hardy

    
  • ·Self-injurious behavior and skills use: an inpatient DBT treatment for borderline patients (BP)

    Página :167-167

    C. Muhtz, L. Friege, T. Grüttert

    
  • ·Prevalence and clinical characterization of personality disorders in a sample of juvenile offenders

    Página :167-168

    R. Sperandeo, A. Buongiovanni, D. Cantone, P. Cotrufo, V. Scarallo, A. Labella

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·A study of quality of life in outpatients with personality disorders

    Página :168-168

    K. Narud, A. Mykletun, A.A. Dahl

    
  • ·Neurosciences, memory and self. Introduction to the work of G.M. Edelman

    Página :168-168

    E.H. Hische

    
  • ·Diagnostic procedure in psychiatry: the structuralist approach

    Página :168-168

    J. Zislin, V. Kuperman

    
  • ·Contemporary history of psychiatry

    Página :168-169

    E. Kringlen

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Generating prediction rules: dependence on the mathematical model

    Página :169-169

    F.T.K. Schultze-Lutter

    
  • ·Social stresses in relation to psychiatric morbidity in menopause

    Página :169-169

    A. El-Hinnawey, A. Khafagi, M. Gawad

    
  • ·The comparative clinical analysis of endogenic psychoses in health resort conditions

    Página :169-169

    T. Vyetrila

    
  • ·Coping patterns, health status and personality in burned adults

    Página :169-169

    M. Willebrand, M. Kildal, B. Gerdin, G. Andersson, L. Ekselius

    
  • ·Ten year follow up study quality of life people from FRY

    Página :169-170

    G. Nikolic-Balkoski, L. Leposavic, D. Duisin, J. Barisic-Rojnic, N. Laskovic

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Chernobyl's lessons for psychiatrists

    Página :170-170

    V. Skavysh

    
  • ·Epilepsy neurosurgery: a patient's perspective

    Página :170-170

    K. Kaufman

    
  • ·Feminine, sexual, and reproductive problems of women with mental illness

    Página :170-170

    I. Savvidou, V.P. Bozikas, A. Kafantari, S. Pitsavas, ?. Athanasios

    
  • ·Changes in patients' attitude due to changes in the psychiatry concept

    Página :170-170

    D.M. Gerulaitiene

    
  • ·Quality of life psychotics during the aerial bombing of Yugoslavia

    Página :171-171

    G. Mandic-Gajic, R. Samardzic, Z. Spiric, M. Preradovic

    
  • ·Prader-Willi syndrome and atypical psychoses

    Página :171-171

    W.M.A. Verhoeven, L.M.G. Curfs, S. Tuinier

    
  • ·Evolution of epileptic psychosis

    Página :171-171

    B.A. Kazakovcev, E.L. Maxutova, L.V. Sokolova

    
  • ·Period of adolescence - psychiatric differentiation of symptomatology

    Página :171-171

    L. Leposavic, Z. Barac, A. Lakic, J. Barisic-Rojnic, G. Nikolic-Balkoski, S. Milovanovic

    
  • ·Risperidone oral solution versus haloperidol injection

    Página :171-172

    G. Currier, G. Gharabawi, J. Morein, G. Simpson

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·Formal clinical characteristics of delusional beliefs in psychotic depression

    Página :172-172

    L. Lykouras, R. Gournellis, P. Oulis, A. Fortos, G.N. Christodoulou

    
  • ·Psychotic disorders related with the abuse of substances

    Página :172-172

    J.C. Navarro Barrios, R. Morales Andueza, W. Rodriguez Ganzáles

    
  • ·Pharmacotherapy for ADHD in children and adults in the Scandinavian countries

    Página :172-172

    L.-O. Janols

    
  • ·Pain thresholds and serotonin receptor 2A gene polymorphism in schizophrenic families

    Página :172-172

    U. Lubov, M. Alfimova, V. Golimbet

    
  • ·24 hour-HRV in relation with weight and BMI in 92 mentally healthy probands

    Página :173-173

    J. Acker, W.P. Kaschka, G. Topf

    
  • ·Behavioral activation or inhibition during emotional stress

    Página :173-173

    K. Seigel, J.-E. Broman, J. Hetta

    
  • ·P3 and negative disorders scores in patients with schizophrenia

    Página :173-173

    I. Lebedeva, V. Kaleda, V. Orlova, E. Fedorova

    
  • ·Psychopathology of schizophrenia and gating of auditory evoked potentials P50

    Página :173-173

    J. Wegrzyn

    
  • ·A specialized group- treatment programme for depressive inpatients. Catamnestic results

    Página :174-174

    F. Schwärzler, H. Smoltczyk, A. Batra, G. Buchkremer

    
  • ·Artistic activity as a way of overcoming splitting in a borderline female homosexual patient

    Página :174-174

    E. Paliokosta, I. Vartzopoulos, E. Papastathopoulos, A. Theodorou, M. Agelopoulou, E. Messini

    
  • ·Family therapy in the group setting

    Página :174-174

    V. Stalekar, S. Borovecki-Jakovljev

    
  • ·Bibliotherapy - cognitive-behavioral self help strategies in patients with major depression

    Página :174-175

    G. Wiesegger, M. Schloegelhofer, H. Eder, U. Itzlinger, F. Leisch, U. Bailer, K. Hornik, G. Jörgl, U. Willinger, H.N. Aschauer

    Resumen Resumen Esquema Esquema

• Posters, Monday, 6 May 2002

  • ·The healing book

    Página :175-175

    I. Török

    
  • ·The rehabilitation program for a child with the imdesired behavior

    Página :175-175

    M. Banjanin, I. Slavicek

    
  • ·Compliance for rehabilitation at patients with psychotic disorders

    Página :175-175

    M. Ienciu

    
  • ·Life events, social support and the onset of major depressive episode

    Página :175-175

    U.S. Leskela, T.K.. Melartin, P.S. Lestela-Mielonen, H.J. Rytsala, T.P. Sokero, M.E. Heikkinen, E.T. Isometsa

    
  • · New chronics - do they need psychiatry-adjacent homes?

    Página :176-176

    M. Franz, T. Meyer, C. Adenaw, B. Gallhofer

    
  • ·Predictors of health-related distress in family caregivers

    Página :176-176

    M. Franz, T. Meyer, B. Gallhofer

    
  • ·Restrictiveness of psychiatric institutions - a changing pattern

    Página :176-176

    B. Hanewald, M. Franz, T. Meyer, B. Gallhofer

    
  • ·The Croatian population attitudes towards the mentally ill via an anti-stigma questionnaire

    Página :176-176

    I. Filipcic, D. Marcinko, J. Grubisin, L. Hotujac

    
  • ·What does psychiatry mean to patients, relatives, and psychiatry professionals?

    Página :176-177

    I. Munk

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Duration of the initial prodrome and prediction of schizophrenia

    Página :179-179

    F.T.K. Schultze-Lutter, J. Klosterkötter, M. Leweke, A. Wieneke

    
  • ·Trait and state-trait markers of schizophrenia

    Página :179-179

    A. Wieneke, F.T.K. Schultze-Lutter, J. Klosterkötter

    
  • ·The initial prodrome of schizophrenia: A case report

    Página :179-179

    A. Wieneke, F.T.K. Schultze-Lutter

    
  • ·Medication compliance in schizophrenics in the post-hospitalization treatment phase

    Página :179-180

    G. Längle, M. Köster, G. Eschweiler

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Who says what? - Statements by schizophrenics and their psychiatrists on the current neuroleptic medication

    Página :180-180

    G. Längle, M. Köster, H. Waschulewski

    
  • ·Self-control and frontal lobe function in psychosis

    Página :180-180

    J.-Anull. Jansson, B. Gervind, S. Warkentin

    
  • ·Cannabis use and the expression of psychosis vulnerability in daily life

    Página :180-180

    H. Verdoux, C. Gindre, F. Sorbara, M. Tournier, J. Swendsen

    
  • ·Cannabis use and dimensions of psychosis in a non-clinical population of female subjects

    Página :180-181

    H. Verdoux, F. Sorbara, C. Gindre, J. Swendsen, J. van Os

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Lycanthropy - psychopathology and psychodynamics

    Página :181-181

    P. Garlipp, T. Gödecke-Koch, H. Haltenhof, D.E. Dietrich

    
  • · State of suicidality in schizophrenia - a case report

    Página :181-181

    P. Garlipp, M. Ziegenbein, H. Haltenhof

    
  • ·Effect of risperidone versus haloperidol on sleep in schizophrenics

    Página :181-181

    J. Haffmans, H. Oolders, E. Hoencamp, J. Arends

    
  • ·Genotype-environment interaction in the Finnish adoptive family study

    Página :181-181

    P. Tienari, L.C. Wynne

    
  • ·Predictors of admission status in first episode schizophrenia

    Página :181-182

    B.D. Kelly, M. Clarke, S. Browne, M. Gervin, A. Lane, C. Larkin, E. O'Callaghan

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Association between a functional promoter MAOA variant and schizophrenia

    Página :182-182

    E.G. Jönsson, N. Norton, K. Forslund, M. Mattila-Evenden, G. Rylander, M. Anullsberg, M.J. Owen, G. Sedvall

    
  • ·Association study and meta-analysis of a DRD3 gene Ser9Gly variant and schizophrenia

    Página :182-182

    E.G. Jönsson, L. Flyckt, E. Burgert, M.-A. Crocq, K.L. Forslund, M. Mattila-Evenden, G. Rylander, M. Anullsberg, V.L. Nimaonkar, G. Edman, L. Bjerkentstedt, F.-A. Wiesel, G. Sedvall

    
  • ·Data mining in schizophrenia in the Human Brain Informatics Project

    Página :182-182

    H. Hall, S. Arnborg, I. Agartz, G. Sedvall

    
  • ·Pindolol augmentation in aggressive schizophrenic patients

    Página :182-182

    I. Modai, N. Caspi, P. Barak, A. Waisbourd, E. Zbarsky, S. Hirschmann, M. Ritsner

    
  • ·Paroxetine binding in aggressive schizophrenic patients

    Página :183-183

    I. Modai, A. Gibel, B. Rauchverger, M. Ritsner, E. Klein, D. Ben Shachar

    
  • ·Mitochondrial function in neuroleptic-free and medicated schizophrenia

    Página :183-183

    A. Gardner, R. Wibom, I. Nennesmo, U. von Döbeln, H. Beier, L. Hagenfeldt, T. Hällström

    
  • ·Schizophrenia patients who smoke have a faster finger tapping rate

    Página :183-183

    H. Silver, N. Shlomo, C. Hiemke, M.-L. Rao, M. Ritsner, I. Modai

    
  • ·Reversed lateralisation of temporal activation during speech production in thought disordered patients with schizophrenia

    Página :183-183

    T.T.J. Kircher, P.F. Liddle, M.J. Brammer, S.C.R. Williams, R.M. Murray, P.K. McGuire

    
  • ·Monitoring of the psychotherapetic process in the group therapy of schizophrenia

    Página :183-184

    M. Krsmanovic

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·How psychotic are non-psychotic patients?

    Página :184-184

    M.S.S. Hanssen, F. Peeters, S. Radstake, H. Verdoux, J. van Os

    
  • ·Social functioning and neurocognitive deficit in schizophrenia

    Página :184-184

    I.Y. Gurovich, A.B. Shmukler, M.V. Magomedova

    
  • ·Psychiatric comorbidity in schizophrenia with obsessive compulsive disorder

    Página :184-184

    M. Poyurovsky, M. Schneidman, A. Weizman, R. Weizman

    
  • ·QLIS - a new schizophrenia-specific quality of life scale

    Página :184-185

    T. Meyer, M. Franz

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·The subjective/objective dichotomy in schizophrenia-data from Striatal Dopamine Depletion Study

    Página :185-185

    A.G. Awad, L.N.P. Voruganti

    
  • ·Cognitive dysfunctions in prepsychosis

    Página :185-185

    E. Bartok, R. Berecz, T. Glaub, I. Degrell

    
  • ·Reduced energy metabolism in schizophrenia

    Página :185-185

    B.M. Nilsson, A. Forslund, R. Olsson, T. Saldeen, L. Hambreus, F.-A. Wiesel

    
  • ·Acceptance of pharmacological treatment by schizophrenic patients

    Página :185-185

    A. Suwalska, A. Rajewski, D. Lojko, A. Czech, P. Klonowska, J. Rybakowski

    
  • ·Integrative index of quality of life and its possibilities in diagnosis and therapy of patients with schizophrenia

    Página :186-186

    N.A. Maruta

    
  • ·Left eyedness is associated with a disproportionate birth weight/birth length ratio in schizophrenia

    Página :186-186

    R. Valigi Björck, C. Nordin

    
  • ·Body composition changes in patients with schizophrenia

    Página :186-186

    B.M. Nilsson, A. Forslund, R. Olsson, L. Hambreus, F.-A. Wiesel

    
  • ·Ziprasidone vs olanzapine in schizophrenia: a 6-month extension study

    Página :186-187

    O. Simpson, R.L. Horne, P. Weiden, T. Pigott, M. Bari, S.J. Romano

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Patient knowledge about schizophrenia and treatment compliance

    Página :187-187

    P. Melcer, J. Rabe-Jablonska

    
  • ·Neuropsychological function in schizophrenia

    Página :187-187

    H. Nyman

    
  • ·Gender and clinical symptoms in schizophrenia

    Página :187-187

    B.J. Havaki-Kontaxaki, V.P. Kontaxakis, S.S. Stamouli, C.T. Kollias, M.M. Margariti, G.N. Christodoulou

    
  • ·Plasma concentrations of amino acids in chronic schizophrenics

    Página :187-187

    A. Tortorella, P. Monteleone, V. De Luca, B. De Luca, M. Maj

    
  • ·P300 Brain Microstate in deficit and nondeficit schizophrenia

    Página :188-188

    A. Forte, A. Bernardo, F. Caputo, P. Bucci, A. Mucci, S. Galderisi, M. Maj

    
  • ·Neurological soft signs (NSS) in schizophrenia

    Página :188-188

    G. Bersani, S. Gherardelli, L. Ramieri, V. Orlandi, D. Pucci, P. Pancheri

    
  • ·Biochemical origin of the schizophrenia and of the behavioral pathologies of schizoid type

    Página :188-189

    G. Chirieleison

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Pharmacokinetics of psychotropics

    Página :189-189

    S. Tuinier, W.M.A. Verhoeven, A.E.S. Sijben

    
  • ·Valproic acid in unstable mood disorder

    Página :189-189

    S. Tuinier, W.M.A. Verhoeven

    
  • ·Atypical antipsychotics in schizophrenia; efficacy and effect on serotonergic parameters

    Página :189-189

    S. Tuinier, W.M.A. Verhoeven, F.M.M.A. van der Heijden, A.E.S. Sijben

    
  • ·Citalopram in mentally retarded patients with depression

    Página :189-190

    W.M.A. Verhoeven, S. Tuinier

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder

    Página :190-190

    A. Broocks, G. Hajak, B. Bandelow, K. Koch, U. Schweiger, F. Hohagen

    
  • ·Relation between sexual dysfunctions and CYP 2D6 activity

    Página :190-190

    A. Zourkova, E. Hadasova

    
  • ·A rare case of neuroleptic malignant syndrome and the NMS spectrum concept

    Página :190-190

    C. Mantas, S. Pappas, V. Mavreas

    
  • ·The effect of olanzapine on dopamine receptor responsivity in schizophrenia

    Página :190-190

    L. Lykouras, J. Hatzimanolis, M. Markianos, P. Oulis

    
  • ·Psychopharmacotherapy or psychotherapy of anxiety disorders - one year results

    Página :190-191

    D. Ignjatovic, M. Ignjatovic

    Resumen Resumen Esquema Esquema

• Poster, Tuesday, 7 2002

  • ·Synthesis of endogenous ethanol during treatment of alcoholic dependence

    Página :191-191

    M. Chuhrova, I. Timofeyev

    
  • ·Creatine kinase levels during treatment with atypical antipsychotic agents

    Página :191-191

    I. Reznik, R. Mester, B. Spivak, M. Kotler, A. Weizman, H.Y. Meltzer

    
  • ·Alteration of hormone status during the treatment of risperidon

    Página :191-191

    Y. Kochetkov, V. Bulanov, L. Gorobets, P. Komissarov

    
  • ·Correction of hyperprolactinemia under risperidon treatment

    Página :192-192

    V. Bulanov, L. Gorobets, L. Vasilenko, G. Granenov, S. Mosolov

    
  • ·Increased use of antidepressants beneficial for depressed individuals

    Página :192-192

    S. Henriksson, G. Isacsson

    
  • ·Cognition in elderly schizophrenic patients: risperidone vs olanzapine

    Página :192-192

    P.D. Harvey, L. Mao, J. Napolitano, G. Gharabawi

    
  • ·Effect of smoking status on olanzapine-induced weight gain in psychosis

    Página :192-192

    L. Robert, G. Gharabawi

    
  • ·Efficacy and safety of a novel long-acting risperidone formulation

    Página :193-193

    J. Kane, M. Eerdekens, S. Keith, M. Lesem, K. Karcher, J.-P. Lindenmayer

    
  • ·Long-term safety of long-acting risperidone microspheres

    Página :193-193

    M. Eerdekens, W.W. Fleischhacker, X. Yang, L. Beauclair, H. Sauret, W. Chrzanowski, S. Martin, O. Gefvert

    
  • ·UKU-SERS-Pat - the UKU side effect self-rating scale

    Página :193-193

    E. Lindström, T. Lewander, U. Malm, U.F. Malt, H. Lublin, U.G. Ahlfors

    
  • ·Plasma leptin and weight gain during clozapine treatment

    Página :193-193

    A. Fuschino, P. Monteleone, S.L. Pia, R. Bencivenga, M. Maj

    
  • ·Improvement in general life functioning with venlafaxine versus fluoxetine in outpatients with major depression

    Página :194-194

    N. Kalin, C. Nemeroff, G. Wan, J. Panish, M. Cantillon

    
  • ·Improvement in social activity level, general life and cognitive functioning with venlafaxine versus fluoxetine in inpatients with melancholic depression

    Página :194-194

    D. Evans, C. Nemeroff, M. Thase, G. Wan, J. Panish, M. Cantillon

    
  • ·Maternal recall bias in the obstetric histories of individuals with and at increased risk of schizophrenia

    Página :194-194

    A.M. McIntosh, S.-E. Holmes, S. Gleeson, J.K. Burns, A. Hodges, M. Byrne, R. Dobbie, P. Miller, S. Lawrie, E. Johnstone

    
  • ·Steroid-induced granulocytosis in neutropenic patients treated by clozapine

    Página :194-195

    P. Murray, A. Laurent

    Resumen Resumen Esquema Esquema

• Poster, Tuesday, 7 2002

  • ·Gene expression profiling of human neuronal cells treated with antipsychotics in vitro

    Página :195-195

    O. von Widdern, O. Wirths, H. Boenisch, T. Bayer, W. Maier, M. Rietschel

    
  • ·Differential distribution of (S)- and (R)- pindolol to the rat brain

    Página :195-195

    H. Yan, T. Lewander

    
  • ·Role for the endogenous cannabinoid system in addiction

    Página :195-195

    F. Rodriguez de Fonseca, I. del Arco, A. Bilbao, B. Ferrer, M. Moreno, M. Navarro

    
  • ·Apomorphine induced motility - gender and dopamine-receptor D2-genotypes

    Página :195-195

    U. Havemann-Reinecke, A. Birke, S. Germeyer, C. Hiemke

    
  • ·APD-induced plasticity and ERK1/2 translocation to the nucleus

    Página :196-196

    P.J. Rogue, S. Freyermuth

    
  • ·Patient satisfaction as a marker of psychiatric treatment quality - the TÜBB2000

    Página :196-196

    G. Längle, M. Schmidt-Hackenberg, H. Waschulewski

    
  • ·Evaluation of psychiatric day treatment

    Página :196-196

    P. Garlipp, H. Haltenhof, B. Brüggemann, H. Vossschulte, K. Stritt, K.-P. Seidler

    
  • ·Data base of quality in psychiatric outpatient treatment. DIPSY

    Página :196-197

    J. Aagaard

    Resumen Resumen Esquema Esquema

• Poster, Tuesday, 7 2002

  • ·Patterns of use of acute psychiatric units in Andalousia (Spain)

    Página :197-197

    J. Miguel Pena-Andreu, J.L. Martínez González, M.I. Rodríguez Idígoras, G. Jiménez Lérida, M. Ruiz Ruiz, M.M. Jiménez Sarmentero

    
  • ·Analysis of subgroups of psychiatric admissions in Andalousia (Spain)

    Página :197-197

    J. Miguel Pena-Andreu, J.L. Martínez González, M.I. Rodríguez Idígoras, M.J. Fernández Terrón, M.D. Martínez Cabrera

    
  • ·A model to evaluate the reliability of the GAF-scale

    Página :197-197

    P. Söderberg, S. Tungstrom, B.-A. Armelius

    
  • ·Comparable unit descriptions for mental health and social services

    Página :197-198

    M.-J. Haack, D. Oberg, B. Sallmen

    Resumen Resumen Esquema Esquema

• Poster, Tuesday, 7 2002

  • ·Quality of life and assessment of acute day vs inpatient treatment

    Página :198-198

    J. Rymaszewska, A. Kiejna, J. Jarosz

    
  • ·Communication improvement in the team-work: from say to share

    Página :198-198

    Q. Quisi

    
  • ·UKU-ConSat - a brief consumer satisfaction rating scale for psychiatry

    Página :198-198

    U.G. Ahlfors, T. Lewander, U. Malm, E. Lindström, U.F. Malt, H. Lublin

    
  • ·The relationship between personality and post traumatic stress disorder

    Página :198-198

    F. Sohrabi

    
  • ·Mental symptoms in victims of sarin poisoning 5 years after the Tokyo subway attack

    Página :199-199

    A. Iwanami, O. Toshiyuki, T. Mamoru, K. Tadafumi, S. Tsukasa, K. Nobumasa

    
  • ·Longterm effects of traumatic experiences in refugees after World War II

    Página :199-199

    C.J. Fischer, J. Struve, M.R. Lemke

    
  • ·Prophylaxis by mexidol of the behavior disturbances after sound stress

    Página :199-199

    E. Loseva, T. Alekseeva, T. Mering

    
  • ·A psychosocial model of posttraumatic stress after childbirth

    Página :199-199

    R. Arzy-Sharabani, M. Amir, M. Hallak

    
  • ·Previous trauma, personality dimensions and psychological symptoms after a stressful event

    Página :199-200

    D. Lecic-Tosevski, S. Priebe, J. Gavrilovic, S. Dimic, G. Knezevic

    Resumen Resumen Esquema Esquema

• Poster, Tuesday, 7 2002

  • ·Personality dimensions in persons with PTSD diagnosis

    Página :200-200

    S. Dimic, D. Lecic-Tosevski, J. Gavrilovic

    
  • ·Relationship between defence, mechanisms and current symptoms after war experience

    Página :200-200

    J. Gavrilovic, D. Lecic-Tosevski, S. Dimic

    
  • ·Bombing of Yugoslavia: stress, personality and traumatic reactions

    Página :200-200

    R. Samardzic, Z. Spiric, G. Knezevic, B. Miljanovic, G. Mandic-Gajic, M. Blagojevic, T. Vukovic

    
  • ·Stability to sound stress and changeability in intestinal microflora

    Página :200-200

    I. Timofeyev, E. Loseva, T. Alekseeva, N. Perminova

    
  • ·Aerial bombing of Yugoslavia: coping styles and traumatic reactions

    Página :200-201

    S. Zeljko, R. Samardzic, G. Knezevic, M. Preradovic, N. Bjelica, T. Zujovic, J. Antonijevic

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Chronic pain in the wives of the Croatian war veterans treated for PTSD

    Página :201-201

    E. Koic, L. Muzinic-Masle, T. Franciskovic, S. Vondracek, V. Djordjevic, J. Per-Koznjal, J. Prpic

    
  • ·Coping styles: a hopelessness and suicide risk

    Página :201-201

    T.-T. Yang, C. Ming

    
  • ·Hostility and depression in diabetic patients

    Página :201-201

    Z. Krausova, M. Dryakova, R. Honzak, V. Tichy

    
  • ·Comparative study of psychotherapy effectiveness of acute life-events depression, acute and posttraumatic stress disorders in men and women

    Página :202-202

    R. Tukaev

    
  • ·Psychosocial consequences of the 1998 Landslide in Samo, Italy

    Página :202-202

    R. Malafronte, F. Catapano, P. Cozzolino, L. Magliano, M. Maj

    
  • ·PTSD and psychosis

    Página :202-202

    N. Bjelica, S. Slovakovic, M. Preradovic, Z. Spine, R. Samardzic

    
  • ·Psychological status of torture survivors in course of time passed after torture

    Página :202-202

    S. Popovic, E. Music, L. Saraba

    
  • ·Identifying psychological symptoms and coping mechanisms of torture victims

    Página :202-202

    A. Kucukalic, A. Bravo-Mehmedbasic, E. Music

    
  • ·Consultation-liaison psychiatry: managing suicide attempters

    Página :203-203

    J. del Rio Vega, M. Saenz Herrero

    
  • ·Physical illness and suicide in the elderly

    Página :203-203

    M. Waern, E. Rubenowitz, B. Runeson, I. Skoog, K. Wilhelmsson, P. Allebeck

    
  • ·Assessment of medical consumption among suicide attempters

    Página :203-203

    M. Walter, J.B. Garre, F. Eudier, W. Martineau, J.J. Chavagnat, F. Chastang, D. Levy, N. Nabhan-Abou, M. Nguyen, L. Lemoigne, C. Chanudet, J.P. Cordier, L. Cadiet, D. Houdet, P. Dhont

    
  • ·Effects of climatic factors on suicide attempts in Northern Turkey

    Página :203-203

    Z. Doganay, H. Guz, A. Ozkan, T. Sunter, L. Altýntop, C. Kati, E. Colak, H. Guven, D. Aygun

    
  • ·Suicide attempts in Northern Turkey

    Página :204-204

    Z. Doganay, H. Guz, A. Ozkan, T. Sunter, L. Altýntop, E. Colak, C. Kati, H. Guven, D. Aygun

    
  • ·Psychiatric treatments of patients before hospitalisation after a tentamen

    Página :204-204

    F.A. Orha, D.F. Zullino, P. Baumann

    
  • ·Risk factors for suicidal ideation and attempts among psychiatric patients with major depressive disorder

    Página :204-204

    T.P. Sokero, U.S. Leskela, H.J. Rytsala, P.S. Lestela-Mielonen, T.K. Melartin, E.T. Isometsa

    
  • ·Risk factors of suicide in in-patients and recently discharged patients with affective disorders

    Página :204-204

    E.H. Høyer, R.W. Licht, P.B. Mortensen

    
  • ·Antidepressants in 15432 suicides in Sweden 1992-2000

    Página :204-205

    G. Isacsson, P. Holmgren, J. Ahlner, U. Bergman

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Repeated suicide within families

    Página :205-205

    B.S. Runeson, M. Anullsberg

    
  • ·Suicidal behaviour of psychiatric in-patients

    Página :205-205

    H. Spießl, B. Hübner-Liebermann, C. Cording

    
  • ·Temperament-traits relevant to suicidal behaviour in MDD patients

    Página :205-205

    B. Pendse, Anullsa Westrin, G. Engström, L. Träskman-Bendz

    
  • ·Suicide after discharge from psychiatric hospital in Oslo, Norway

    Página :205-205

    F.A. Walby, H. Ekeland, L. Mehlum

    
  • ·Time perspective in suicide attempters

    Página :206-206

    B. Ripke

    
  • ·Self-aggression of soldiers and possibilities of psychoprophylaxis

    Página :206-206

    A. Florkowski, W. Gruszczynski

    
  • ·Suicide in mental health service users diagnosed with schizophrenia

    Página :206-206

    I. Hunt, J. Meehan, J. Robinson, J. Shaw, L. Appleby

    
  • ·Conversion disorders and the subtypes

    Página :206-207

    H. Guz, Z. Doganay, A. Ozkan, E. Colak, A. Tomac, G. Sarýsoy

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Conversion and somatization disorders: the dissociative symptoms and other characteristics

    Página :207-207

    H. Guz, Z. Doganay, A. Ozkan, E. Colak, A. Tomac, G. Sarýsoy

    
  • ·Somatoform disorders and depression in pregnant women with preterm labor

    Página :207-207

    E. Lasy, E. Lasaja

    
  • ·Somatoform disorder or affective disorder? Questions about a correct diagnosis

    Página :207-207

    C. Pruneri, S. Damiano, M. Gatti, E. Pellegrini, F. Furlani

    
  • ·Place and characteristics of somatoform disorders in the continuum of affective somatization

    Página :207-208

    V. Solozhenkin, A. Kim

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·New therapy of a form of somatised disorders

    Página :208-208

    V. Solozhenkin, Y. Kolesova

    
  • ·Sexual disturbances in 4557 depressed patients: a French survey

    Página :208-208

    M. Bonierbale

    
  • ·Monitoring of quality of life and outcomes in transsexuals before and after sex-change treatment

    Página :208-208

    D. Duisin, Z. Rakic, G. Nikolic-Balkoski, T. Cavic

    
  • ·Sleep quality in schizophrenic patients taking antipsychotics

    Página :209-209

    A. Schreiner

    
  • ·Sleep deprivation effects on subjective sleep clomplaints

    Página :209-209

    F. Cavaglia, D. Pires-Barreira, L. Paula, A. Matos-Pires, F. Arriaga

    
  • ·Circannual variation of sleep disturbances and psychiatric symptoms

    Página :209-209

    D. Neckelmann, A. Mykletun, A.A. Dahl

    
  • ·Sleep complaints predict coronary artery disease mortality in males: a twelve-year follow-up study of a middle-aged Swedish population

    Página :209-209

    L. Mallon, J. Hetta, J.-E. Broman

    
  • ·Features and correlates of insomnia in medical in-patients

    Página :209-210

    M. Spiliotis, M. Liarou, T. Tsouti, E. Ibanda, N. Polonifis, J. Kogeorgos

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Alcohol dependence in the elderly - characteristics and consequences

    Página :210-210

    H. Shahpesandy, I. Doci

    
  • ·Hepa-Merz in treatment of alcohol and drug-induced encephalopathy

    Página :210-210

    I. Vlokh, L. Zhivotovska, S. Mikhnyak, N. Petryna

    
  • ·Tiapride and carbamazepine in the treatment of alcohol withdrawal

    Página :210-210

    M. Franz, H. Dlabal, J. Ulferts, H. Gruppe, B. Gallhofer

    
  • ·Cognitive evoked potentials P300 in patients with alcohol dependence F10.1

    Página :210-211

    Z. Sundric

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Perception of emotions by alcoholic patients during long-term treatment with naltrexone

    Página :211-211

    M. Ziókowski, A. Araszkiewicz, J.K. Rybakowski

    
  • ·Childhood sexual abuse in a sample of female alcohol dependent inpatients

    Página :211-211

    J. Martínez-Raga, F. Keaney, J. Marshall, D. Best, D. Ball, J. Strang

    
  • ·Switching to mirtazapine from other antidepressants in addictological practice

    Página :211-211

    M.F. Kerekes

    
  • ·Dopamine D2 receptors and transporters in type 1 and 2 alcoholics

    Página :212-212

    E. Tupala, H. Hall, K. Bergstöm, T. Mantere, P. Räsänen, T. Särkioja, J. Tiihonen

    
  • ·Korsakoff's psychosis: MHPG and cognitive symptoms under treatment with reboxetine

    Página :212-212

    T.F. Reuster, J. Büchler, J. Oehler, P. Winiecki

    
  • ·Alcohol dependence is associated with a NMDA-receptor 2B gene variant

    Página :212-212

    G. Schumann, D. Rujescu, A. Szegedi, P. Singer, S. Wiemann, S. Wellek, I. Giegling, C. Klawe, I. Anghelescu, A. Heinz, R. Spanagel, K. Mann, F.A. Henn, N. Dahmen

    
  • ·The association between alcohol and suicide rate: results of time-series analysis

    Página :212-212

    Y.E. Razvodovsky

    
  • ·Endogenous ethanol and microbe associations at patients with alcoholic dependence

    Página :213-213

    N. Perminova, M. Chuhrova, I. Timofeyev

    
  • ·Efficacy of oxcarbazepin in alcohol relapse prevention - a pilot study

    Página :213-213

    B. Croissant, T. Scherle, A. Heinz, K. Mann

    
  • ·Addiction, stigma and the movies

    Página :213-213

    G. Cape

    
  • ·Population survey of drug abusers attending a Swiss detoxification unit

    Página :213-213

    S.L. Krenz, D.F. Zullino, G. Zimmermann, B. Favrad, C. Eichenberger, S. Dieckman, J. Besson

    
  • ·Topiramate in multidrug withdrawal - comparison with clonidine

    Página :213-214

    S.L. Krenz, G. Zimmermann, M. Pin, S. Kolly, J. Besson, D. Zullino

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Longitudinal study of psychiatric comorbidity in MDMA users

    Página :214-214

    J.M. Gines, R. Blanco, M. Torrens, R. Martin-Santos, S. Poudevida, P.N. Roset, M. Farre, R. de la Torre

    
  • ·Affective disorders and craving to drugs in heroin addiction

    Página :214-214

    M. Rokhlina, A. Kozlov, S. Mohnatchev

    
  • ·Gambling co-morbidity in heroin addicts in MMT

    Página :214-214

    M. Campana, M. Metzger, M. Riglietta, L. Tidone

    
  • ·Gender differences among heroin users

    Página :214-215

    S.O. Mokhnatchev

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Heroin addiction and its social consequences in Russia

    Página :215-215

    L. Tchistyakova

    
  • ·Patient or client, what substance misuse attenders want to be called, who they want to be treated with, where they want to be seen

    Página :215-215

    F. Keaney, J. Martinez-Raga

    
  • ·Does cannabinoid exposure sensitize the brain to amphetamine effects?

    Página :215-215

    M. Stridh, S. Kuhne, Y. Hurd, J. Franck

    
  • ·Cocaine mediated dopamine transmission and behavior in depressed rats

    Página :215-216

    P. Fagergren, D.H. Overstreet, Y.L. Hurd

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Impaired dopamine-related motivation in nicotine addicts after overnight abstinence

    Página :216-216

    L.G. Schmidt, H. Budde, M. Smolka

    
  • ·Treatment of drug addicts - drop out, completion and stages of change

    Página :216-216

    A. Günthner, K. Mann, G. Buchkremer, T. Bader

    
  • ·Feasibility, efficacy and safety issues in pharmacotherapy of opioid addicts

    Página :216-216

    M. Kuntze, A. Bullinger, D. Ladewig

    
  • ·Non-alcohol substance misuse, outcome and intensive case management

    Página :216-216

    C. Samele, E. Walsh, C. Gilvarry, C. Manley, T. Tattan, T. Fahy, R. Murray

    
  • ·Gender related differences in heroin addicts: trauma and comorbidity

    Página :217-217

    R. Basdekis-Jozsa, M. Krausz, P. Degkwitz, U. Verthein

    
  • ·Therapy of insomnia in heroin patients

    Página :217-217

    L. Benko

    
  • ·Drug abuse among Bosnian adolescents and its risk related behaviour

    Página :217-217

    I. Licanin, E. Music, A. Dedic, B. Paralija

    
  • ·Internet-based psychiatric assessment of tinnitus patients

    Página :217-217

    V. Kaldo-Sandström, P. Carlbrin, L. Ström, G. Andersson

    
  • ·Randomized controlled trial of internet-based treatment of insomnia

    Página :218-218

    G. Andersson, L. Strom, R. Pettersson

    
  • ·Combining 1-Hz and 10-Hz rTMS in the treatment of depressives

    Página :218-218

    A. Conca, W. Peschina, A. Hausmann, P. Koenig

    
  • ·Dynamics of vegetative regulation in transcranial magnetic stimulation of depressed patients

    Página :218-218

    T.S. Melnikova, S. Mosolov, E. Tsoukarzi, S. Kapiletti

    
  • ·Accessibility of drug treatment institutions for migrants in Germany

    Página :218-218

    A. Heinz, S. Krieg, C. Hunner, S. Penka

    
  • ·Psychiatric services to traumatized populations

    Página :218-219

    M. Kastrup

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Ethnic classification in psychiatric research: are human beings colour-coded?

    Página :219-219

    S.P. Singh

    
  • ·Anxiety disorders related with the acculturation stress

    Página :219-219

    I.C. Navarro Barrios, R. Morales Andueza, W. Rodriguez Ganzáles

    
  • ·Abuse of alcohol and criminal behaviors in immigrants: a review

    Página :219-219

    J.C. Navarro Barrios, R. Morales Andueza, A. Cañabate Prados, W. Rodriguez Ganzáles, B. Romero Montero

    
  • ·Schizophrenia as a systemic disorder - studies of peripheral and central biological functions

    Página :219-219

    L. Flyckt, G. Edman, L. Bjerkenstedt, N. Venizelos, L. Hagenfeldt, F.-A. Wiesel

    
  • ·Neurological signs in schizophrenia: trait markers of brain dysfunction

    Página :220-220

    C. Arango

    
  • ·Speech processing cortical representation: invariance in left superior temporal sulcus and variability in Broca's area

    Página :220-220

    S. Dollfus, G. Josse, M. Joliot, F. Crivello, D. Papathanassiou, B. Mazoyer, N. Tzourio-Mazoyer

    
  • ·Genotyping Reelin in multiple affected families with schizophrenia: a suitable marker for the vulnerability to develop schizophrenia?

    Página :220-220

    P. Falkai, I. Neidt, R. Tepest, D. Müller, T. Schulze, M. Gross, W. Maier, H. Schild, H. Block, M. Rietschel

    
  • ·Introducing a new recruitment design for genetic association studies in opioid dependence

    Página :220-220

    P. Franke, B. Wendel, M. Knapp, S.G. Schwab, W. Maier, D.B. Wildenauer, M.R. Hoehe

    
  • ·In opioid dependence

    Página :220-220

    S. Galderisi

    
  • ·Schneiderian psychotic symptoms in bipolar patients

    Página :221-221

    A. González-Pinto Arrillaga, J. van Os, J.L. Pérez de Heredia, F. Mosquera, A. Aldama, J.A. Micó

    
  • ·Rheumatoid arthritis and schizophrenia: an exclusion of association

    Página :221-221

    P. Gorwood

    
  • ·Dysfunction of the brain reward system in addiction

    Página :221-221

    A. Heinz, J. Wrase, S. Grüsser, D. Braus, P. Bartenstein, K. Mann

    
  • ·Activation differences in sufficient and insufficient learning - an fMRI study of procedural motor learning

    Página :221-221

    R. Heun, N.R. Freymann, D.O. Granath, F. Jessen, J. Reul

    
  • ·Pharmacoeconomics of the treatment of agoraphobia with panic disorder

    Página :222-222

    M. Ignjatovic, D. Ignjatovicova, L. Hosak

    
  • ·Clinical features of major depression in offspring and history of major depression in parents: findings from a prospective community study of adolescents and young adults

    Página :222-222

    R. Lieb, M. Höfler, H.-U. Wittchen

    
  • ·Reversal of paracingulate sulcus asymmetry patterns in men with early-onset schizophrenia

    Página :222-222

    J.B. Le Provost, D. Bartrés-Faz, M.L. Paillère-Martinot, E. Artiges, S. Pappata, C. Recasens, M. Pérez-Gómez, M. Bernardo, I. Baeza, F. Bayle, J.L. Martinot

    
  • ·Family psychoeducation in schizophrenia and quality of life

    Página :222-223

    L. Motlová, E. Dragomirecká, F. Snullpaniel

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Service and non-service costs of psychiatric patients attending a community mental health centre in Italy

    Página :223-223

    M. Percudani, C. Barbui, J. Beecham, M. Knapp

    
  • ·Depression, anxiety, aggression, impulsivity and suicidal behavior

    Página :223-223

    W. Pitchot, C. Paquay, J. Reggers, M. Ansseau

    
  • ·Brain glucose metabolism after dextromethorphan challenge in alcohol dependent males and controls

    Página :223-224

    C.G. Schütz, T. Rüther, R. Koch, M. Soyka, K. Tatsch

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Th1 and Th2 relationship in schizophrenia - immunological, immunogenetic and therapeutic investigations

    Página :224-224

    M.J. Schwarz, M. Riedel, H. Krönig, S. Sokullu, S. Chiang, N. Mueller, M. Ackenheil

    
  • ·The candidate gene approach in affective disorder: the European Collaborative Project on Affective Disorders

    Página :224-224

    D. Souery

    
  • ·Lithium augmentation in venlafaxine non-responders: an open study

    Página :224-224

    G. Bertschy

    
  • ·Childhood routines and obsessive-compulsive disorder in a community sample

    Página :224-225

    Y. Yazgan, A. Cevikaslan, C. Dedeoglu, Sanda Çalý, D. Evans

    Resumen Resumen Esquema Esquema

• Posters, Tuesday, 7 May 2002

  • ·Dissociation, pain threshold and treatment of eating disorders

    Página :225-225

    H. Papezova, A. Yamamova, I. Vurmova, I. Hajkova, M. Kocova

    
  • ·The candidate gene approach in affective disorder: the European Collaborative Project on Affective Disorders

    Página :225-225

    D. Souery

    
  • ·Author index

    Página :227-240

    Resumen Resumen Esquema Esquema